syndrome	score	normalized_score
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	4.5442975	100.0
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	3.4887419000000004	76.77186407800106
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	2.571004511	56.576500790276164
CARTILAGE-HAIR HYPOPLASIA; CHH	2.4382554	53.65527675069689
HEMOGLOBIN--BETA LOCUS	2.2709172	49.972899001440815
PALLISTER-HALL SYNDROME	2.149031413	47.290728941051945
OROTIC ACIDURIA	2.143700882	47.17342739994466
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	2.0	44.01120305173682
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	2.0	44.01120305173682
PHACE ASSOCIATION	1.6633107329999999	36.6021532040981
CRI-DU-CHAT SYNDROME	1.58955819	34.97918413132063
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	1.578629	34.738680731180125
MYOCLONIC EPILEPSY OF LAFORA	1.57284456	34.611390649489834
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	1.5530846	34.17656084356273
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	1.5530846	34.17656084356273
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	1.5530846	34.17656084356273
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	1.5530846	34.17656084356273
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5333333	33.74192160614485
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	1.5297616	33.6633241991749
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.5185101429999999	33.415729119847455
BRANCHIOOTORENAL SYNDROME 1	1.5	33.008402288802614
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	1.4616022	32.16343560253262
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	1.36038576	29.93610695602566
CARNEY COMPLEX, TYPE 1; CNC1	1.3560602999999998	29.840922606849567
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	1.35178799	29.746907855394593
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	1.34538599	29.606027994425983
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	1.3315976109999998	29.30260642046433
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.3239250999999999	29.133768200695485
SITOSTEROLEMIA	1.3179360999999998	29.001976653157058
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	28.72953630346605
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	1.30305941	28.674606140993188
#610984 COMPLEMENT FACTOR I DEFICIENCY; CFID;;COMPLEMENT COMPONENT 3 INACTIVATOR DEFICIENCY;;C3 INACTIVATOR DEFICIENCY	1.2949066999999999	28.495200853377224
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	1.28628032	28.305372172486504
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	1.28628032	28.305372172486504
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	1.2844828	28.265816663631725
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	1.27854182	28.13508182507858
#609529 IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2;;IMMUNOGLOBULIN A, SELECTIVE DEFICIENCY OF, TACI-RELATED;;IgA, SELECTIVE DEFICIENCY OF, TACI-RELATED	1.2593874	27.71357729109945
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	1.250843882	27.525572038362366
#180295 RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2	1.25	27.507001907335514
HYPERPARATHYROIDISM 2	1.25	27.507001907335514
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	1.23537749	27.185224778967488
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	1.2270574720000003	27.00213777817144
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	1.22040251	26.855691336229636
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	1.2011488	26.432001866075005
THYROID CANCER, NONMEDULLARY, 2; NMTC2	1.2	26.40672183104209
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	1.177044631	25.901575127948824
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	1.167857	25.699395781196106
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	1.166667	25.67320911538032
#613108 CANDIDIASIS, FAMILIAL, 4; CANDF4;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS	1.166667	25.67320911538032
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	1.16192678	25.568897722915366
MOWAT-WILSON SYNDROME; MOWS	1.153045141	25.37345191418476
BLAU SYNDROME	1.152027	25.35104710904161
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	1.13042931	24.875776949022374
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	1.120559743	24.658591190387515
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	1.1178161	24.598215675800276
#613860 IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY;;FICOLIN 3 DEFICIENCY;;FCN3 DEFICIENCY	1.111111	24.450665917009175
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	1.111111	24.450665917009175
NEUTROPHIL CHEMOTACTIC RESPONSE	1.0930521	24.053268959613668
MEVALONIC ACIDURIA; MEVA	1.0910725920000002	24.009708695348404
IMMUNODEFICIENCY 61; IMD61	1.0872264999999999	23.92507312736457
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	1.0701971000000001	23.55033093673995
IMMUNODEFICIENCY 13; IMD13	1.0662927	23.464412266142347
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	1.0625	23.380951621235184
WHIM SYNDROME	1.0609211	23.346206976985997
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	1.059760571	23.32066883825278
FETAL IODINE DEFICIENCY DISORDER	1.0555556	23.228135921998945
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	1.0494082	23.092858687178822
TIMOTHY SYNDROME; TS	1.047916243	23.06002727594309
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	1.0445709	22.98641099091774
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.032388372	22.718327134172004
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	1.02953002	22.655427379039335
FOLATE MALABSORPTION, HEREDITARY	1.026759763	22.594466207373088
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	1.025	22.55574156401512
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	1.023868441	22.530840927558113
LYMPHOID INTERSTITIAL PNEUMONIA	1.0208333	22.464050824137285
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	1.0196078	22.437082959467332
OCULOSKELETODENTAL SYNDROME; OCSKD	1.0169828720000003	22.379319839865243
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	1.0139177899999998	22.311870866729123
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	1.0109732230000001	22.247073898660908
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0104728500000002	22.236062889808604
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	1.010129341	22.228503767634052
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	1.010101	22.227880106881205
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	1.002129341	22.052458955427106
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	1.0020574720000002	22.050877434851046
THYROTROPIN-RELEASING HORMONE DEFICIENCY	1.00121359	22.03230730382419
ICHTHYOSIS AND MALE HYPOGONADISM	1.000915751	22.025753177471323
108450 ASYMMETRIC SHORT STATURE SYNDROME	1.0	22.00560152586841
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	1.0	22.00560152586841
TEMPORAL ARTERITIS	1.0	22.00560152586841
KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE	1.0	22.00560152586841
ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA	1.0	22.00560152586841
HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	1.0	22.00560152586841
#557000 PEARSON MARROW-PANCREAS SYNDROME;;SIDEROBLASTIC ANEMIA WITH MARROW CELL VACUOLIZATION AND EXOCRINE PANCREATICDYSFUNCTION	1.0	22.00560152586841
TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD	1.0	22.00560152586841
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	1.0	22.00560152586841
SECRETORY COMPONENT DEFICIENCY	1.0	22.00560152586841
CLUSTER HEADACHE, FAMILIAL	1.0	22.00560152586841
GRANULOMATOSIS WITH POLYANGIITIS	1.0	22.00560152586841
STICKLER SYNDROME, TYPE I	1.0	22.00560152586841
#613789 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2;;C8 DEFICIENCY, TYPE II;;COMPLEMENT COMPONENT 8B DEFICIENCY;;C8 BETA DEFICIENCY;;C8B DEFICIENCY	1.0	22.00560152586841
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	1.0	22.00560152586841
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	1.0	22.00560152586841
#615106 COWDEN SYNDROME 3; CWS3	1.0	22.00560152586841
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	1.0	22.00560152586841
CHROMOSOME 5Q DELETION SYNDROME	1.0	22.00560152586841
CHIARI MALFORMATION TYPE II	1.0	22.00560152586841
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	22.00560152586841
LEISHMANIASIS, TEGUMENTARY	1.0	22.00560152586841
VASCULITIS, LYMPHOCYTIC, NODULAR	1.0	22.00560152586841
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	1.0	22.00560152586841
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	1.0	22.00560152586841
CORONAVIRUS 229E SUSCEPTIBILITY	1.0	22.00560152586841
HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	1.0	22.00560152586841
MOYAMOYA DISEASE 1; MYMY1	1.0	22.00560152586841
BARBER-SAY SYNDROME; BBRSAY	1.0	22.00560152586841
PHEOCHROMOCYTOMA	1.0	22.00560152586841
BIRDSHOT CHORIORETINOPATHY	1.0	22.00560152586841
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	20.870389757712825
BARE LYMPHOCYTE SYNDROME, TYPE II	0.8906478000000001	19.599240586691344
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.8825822	19.421752207024298
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.8763885	19.285456112853527
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.8565341	18.848548097918325
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.83969256	18.477939879596352
ACNE INVERSA, FAMILIAL, 3; ACNINV3	0.833333	18.3379939363565
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.833333	18.3379939363565
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.82431309	18.139505391097305
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.81765995	17.99309904336149
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.81090319	17.84441247519556
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.8004080199999999	17.61345994622931
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.794387151	17.48096710217586
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.7909090999999999	17.40443049778321
IMMUNODEFICIENCY 46; IMD46	0.7746411599999999	17.046444692496472
MANNOSE-BINDING LECTIN DEFICIENCY	0.733333	16.13743378376966
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.7274395	16.007743771176955
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.7222219000000001	15.892927344655583
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.71225241	15.673542720299452
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.709177182	15.60587047833026
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.709177182	15.60587047833026
PENDRED SYNDROME	0.7011487999999999	15.429201103140802
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.7007935	15.421382512918663
IMMUNODEFICIENCY 21; IMD21	0.6862663	15.101702738432069
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.6805555999999999	14.97603534979829
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.674667	14.846453164653065
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.67376499	14.826603892020715
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.667582751	14.690560004049031
#613953 CANDIDIASIS, FAMILIAL, 5; CANDF5;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.6672021	14.682183549822609
GOITER, MULTINODULAR 1	0.666667	14.670408352446115
PARAGANGLIOMAS 1	0.666666	14.670386346844587
PARAGANGLIOMAS 3	0.666666	14.670386346844587
PARAGANGLIOMAS 4	0.666666	14.670386346844587
#605258 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2;;HYPER-IgM SYNDROME 2	0.6619622999999999	14.56687859894736
#300645 ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2; AMCBX2;;ATYPICAL MYCOBACTERIAL INFECTION, DISSEMINATED, X-LINKED 2;;ATYPICAL MYCOBACTERIAL INFECTION, FAMILIAL DISSEMINATED, X-LINKED2;;MYCOBACTERIAL DISEASE, SUSCEPTIBILITY TO, X-LINKED 2;;MYCOBACTERIAL DISEASE, MENDELIAN SUSCEPTIBILITY TO, X-LINKED RECESSIVE2; XRMSMD2	0.642857	14.14645498011519
#615978 IMMUNODEFICIENCY 27B; IMD27B ;;IMMUNODEFICIENCY 27B, MYCOBACTERIOSIS, AUTOSOMAL DOMINANT;; IFNGR1 DEFICIENCY, AUTOSOMAL DOMINANT	0.642857	14.14645498011519
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.6388886	14.059127951019935
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.634238333	13.956796028429036
MIRAGE SYNDROME; MIRAGE	0.633571893	13.94213061534814
SICKLE CELL ANEMIA	0.63095232	13.884485335742214
Polyarteritis nodosa, childhood-onset	0.6179101800000001	13.597485199857626
ZIMMERMANN-LABAND SYNDROME 1	0.616824851	13.573601882359155
CHOPS SYNDROME; CHOPS	0.602057472	13.248636824503679
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.599537	13.193172322014568
#601495 AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT	0.5932360999999999	13.054517227360224
SMITH-MAGENIS SYNDROME; SMS	0.583612023	12.84273362384395
THROMBOCYTOPENIA 1	0.583333	12.836593554889397
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.5825	12.81826288881835
#615607 IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	0.5734521	12.619158406772446
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.5666667	12.469841598178816
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.561745251	12.361542152554932
IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACEGLYCOPROTEIN	0.5596072999999999	12.314495254767099
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.5565476	12.247164715778403
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.5526316	12.160990780203102
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.5517677	12.141980141044902
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.551126	12.127859146545754
WILLIAMS-BEUREN SYNDROME; WBS	0.5483087	12.065862765366923
COWDEN SYNDROME 6; CWS6	0.547118751	12.039677221836818
COWDEN SYNDROME 5; CWS5	0.547118751	12.039677221836818
IMMUNODEFICIENCY 23; IMD23	0.5455363419999999	12.004855359931868
MYELOCEREBELLAR DISORDER	0.54029178	11.88944561838216
PALLISTER-KILLIAN SYNDROME	0.539930851	11.88150315862903
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	11.833995947668479
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.537037	11.817822226647793
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.537037	11.817822226647793
HYPOCHONDROPLASIA	0.537037	11.817822226647793
#608106 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5;;HYPER-IgM SYNDROME 5	0.5369622999999999	11.81617840821381
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.534177882	11.754905615224356
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.533907071	11.748946256269534
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5333333	11.736320080276435
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.53301631	11.72934452464875
PSEUDOACHONDROPLASIA	0.530303	11.669636505972594
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.5294118	11.650025113892742
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.528971042	11.640325968975402
BEHCET SYNDROME	0.527027	11.597546155373852
SANDHOFF DISEASE	0.525	11.552940801080917
WT LIMB-BLOOD SYNDROME	0.5232257199999999	11.513896702405594
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.522654851	11.501334386668125
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.52121359	11.469618571407352
#615615 IMMUNODEFICIENCY 18; IMD18;;CD3-EPSILON DEFICIENCYIMMUNODEFICIENCY 18, SEVERE COMBINED IMMUNODEFICIENCY VARIANT, INCLUDED;;IMMUNODEFICIENCY 18, SCID VARIANT, INCLUDED	0.5208205	11.460968389503549
#615343 PULMONARY HYPERTENSION, PRIMARY, 3; PPH3	0.5196078	11.434282196533127
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.5189646	11.420128193631689
THROMBOCYTOPENIA, CYCLIC	0.51599112	11.35469497760655
BARTH SYNDROME; BTHS	0.51565689	11.347340045408561
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	11.326412938413474
LARON SYNDROME	0.5133333	11.296208049759066
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.5103093	11.22966311074484
CYCLIC NEUTROPENIA	0.5103093	11.22966311074484
ROBERTS SYNDROME; RBS	0.510101	11.225079343947003
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.50680272	11.152498708546261
BOHRING-OPITZ SYNDROME	0.5067900129999999	11.15221908336767
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.50568182	11.127832629795915
RAMON SYNDROME	0.502129341	11.049658192492897
SCHIZOPHRENIA 1; SCZD1	0.50121359	11.029506540889985
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.50121359	11.029506540889985
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.500915751	11.02295241453712
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.500843882	11.021370893961057
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	11.021370893961057
#609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR;;STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;;STICKLER SYNDROME, ATYPICALRHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD,INCLUDED	0.5	11.002800762934205
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	11.002800762934205
HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS	0.5	11.002800762934205
OMODYSPLASIA	0.5	11.002800762934205
COMBINED SAPOSIN DEFICIENCY	0.5	11.002800762934205
VARICELLA, SEVERE RECURRENT	0.5	11.002800762934205
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.5	11.002800762934205
HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION ISUNKNOWN OR UNCERTAIN	0.5	11.002800762934205
ENCEPHALOMALACIA, MULTILOCULAR	0.5	11.002800762934205
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	11.002800762934205
TAKAYASU ARTERITIS	0.5	11.002800762934205
GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS	0.5	11.002800762934205
#300584 IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA;;IMMUNODEFICIENCY, ISOLATED;;IMMUNODEFICIENCY, PURE	0.5	11.002800762934205
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.5	11.002800762934205
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.5	11.002800762934205
SCHIZOPHRENIA	0.5	11.002800762934205
PULMONARY EDEMA OF MOUNTAINEERS	0.5	11.002800762934205
GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD	0.5	11.002800762934205
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.5	11.002800762934205
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.5	11.002800762934205
ASCITES, CHYLOUS	0.5	11.002800762934205
STICKLER SYNDROME, TYPE II	0.5	11.002800762934205
GOITER, MULTINODULAR 2	0.5	11.002800762934205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.488691082	10.753941219737484
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.47571763300000003	10.46845267062731
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	10.262728177457573
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.46565859	10.247097378637731
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.460092633	10.124615146785613
HASHIMOTO THYROIDITIS	0.458333	10.085893364155845
PSEUDOXANTHOMA ELASTICUM; PXE	0.45204042	9.947421356106197
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.45	9.902520686640786
CENTRALOPATHIC EPILEPSY	0.44841259999999994	9.86758899477862
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	9.86758899477862
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	9.86758899477862
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.444445	9.780279570164584
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.444445	9.780279570164584
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.4432159	9.753232485329141
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.436881623	9.613842909712668
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.43247830000000004	9.516945138384978
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.4286139	9.43190669184841
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.427050182	9.397496136641582
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.42641340000000005	9.383483365690738
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.42367259999999995	9.323170413028636
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.41972650000000006	9.236334108847409
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.41909019000000003	9.222331724540481
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.414761672	9.127080082234935
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.4147368	9.12653275891378
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.41167445100000005	9.059143927086641
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.40627079	8.940233116339764
SUPRAVALVULAR AORTIC STENOSIS	0.4047616	8.90702248257294
Split hand/foot malformation 1 (SHFM1)	0.4047616	8.90702248257294
TUBEROUS SCLEROSIS	0.403341151	8.87576464789112
THYROID CANCER, NONMEDULLARY, 1; NMTC1	0.4011498	8.827542650981808
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.397732482	8.75234251278663
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.395833	8.71054326878907
JOUBERT SYNDROME 26	0.387114672	8.518691216849248
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	8.416673864332166
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.3790367	8.340930583880127
#300622 TN POLYAGGLUTINATION SYNDROME; TNPS;;GALACTOSYLTRANSFERASE DEFICIENCY	0.3768113	8.29195931824446
EPILEPSY, JUVENILE ABSENCE	0.3752738	8.258125705898436
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	8.258125705898436
#614042 MOYAMOYA DISEASE 5; MYMY5	0.375	8.252100572200654
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.3749997	8.252093970520196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.3741988	8.234469684258128
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.372582051	8.198892149996782
ALSTROM SYNDROME; ALMS	0.369309892	8.126886322913498
DEIODINASE, IODOTHYRONINE, TYPE I; DIO1	0.36781579999999997	8.09400792971851
THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT	0.36781579999999997	8.09400792971851
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.36363599999999996	8.002028916460684
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.36282939	7.984278978213904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	7.978544142411451
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.3619044	7.963924016858492
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.3619044	7.963924016858492
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	7.951759320334991
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.36111099999999996	7.946464772607867
HEINZ BODY ANEMIAS	0.36111099999999996	7.946464772607867
141700 HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES	0.36111099999999996	7.946464772607867
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.36036	7.929938565861941
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.35974382	7.916379154313731
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	7.914288182056743
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.359418282	7.909215494804202
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.358008131	7.878184273806898
AICARDI SYNDROME; AIC	0.3578283	7.8742269844788995
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.3573013	7.862630032474767
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.35655872	7.846289112893687
#269840 SELECTIVE T-CELL DEFECT; STCD	0.3555552	7.824206051650448
#604571 BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY	0.3552632	7.817780416004894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.353044782	7.76896279347908
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.352631872	7.759876460553035
WEBB-DATTANI SYNDROME; WEDAS	0.35233403300000005	7.753322334200171
KNIEST-LIKE DYSPLASIA, LETHAL	0.3518515	7.742703905279089
RHYNS SYNDROME; RHYNS	0.35178799	7.74130632952618
SECKEL SYNDROME 7; SCKL7	0.351398841	7.732742871697991
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.3508769	7.7212572460319775
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.3508769	7.7212572460319775
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.35	7.701960534053944
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	7.697600828290842
IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTSAND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES	0.349462	7.690121520433027
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.349102282	7.682205709463344
ALAGILLE SYNDROME 1; ALGS1	0.34834070000000006	7.665446639442071
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	7.658805348901562
THANATOPHORIC DYSPLASIA, TYPE I	0.347510182	7.647170591274009
CHROMOSOME 1P36 DELETION SYNDROME	0.345238623	7.597183569077509
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.34464759	7.5841775323908704
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.344351893	7.577670542036476
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.34435189299999996	7.577670542036474
NIEMANN-PICK DISEASE, TYPE C2	0.34435189299999996	7.577670542036474
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.34234201	7.533441857624858
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.34165381300000003	7.518297668671561
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.33901482	7.460225040284005
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.336815982	7.411838287436067
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.335694361	7.387156342647021
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.33454659	7.361898951378073
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.33454659	7.361898951378073
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.3341824	7.3538847313583675
THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	0.3333333	7.335199775102752
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.333333	7.335193173422294
Potocki-Shaffer syndrome	0.333333	7.335193173422294
#610799 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1INVASIVE PNEUMOCOCCAL DISEASE, PROTECTION AGAINST, INCLUDED	0.333333	7.335193173422294
PSEUDO-VON WILLEBRAND DISEASE	0.333333	7.335193173422294
IMMUNODEFICIENCY 25	0.333333	7.335193173422294
PEMPHIGUS VULGARIS, FAMILIAL	0.333333	7.335193173422294
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.333333	7.335193173422294
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2	0.333333	7.335193173422294
DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA	0.333333	7.335193173422294
#300640 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	0.333333	7.335193173422294
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.333333	7.335193173422294
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.333333	7.335193173422294
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.333333	7.335193173422294
ATR-16 syndrome	0.333333	7.335193173422294
#610551 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1;;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 1; IIAE1	0.333333	7.335193173422294
GRANGE SYNDROME; GRNG	0.333333	7.335193173422294
WAGR 11p13 deletion syndrome	0.333333	7.335193173422294
AUTOIMMUNE DISEASE	0.333333	7.335193173422294
250700 METHEMOGLOBIN REDUCTASE DEFICIENCY;;NADPH-DEPENDENT METHEMOGLOBIN REDUCTASE DEFICIENCY;;TPNH-METHEMOGLOBIN REDUCTASE DEFICIENCY	0.333333	7.335193173422294
THANATOPHORIC DYSPLASIA, TYPE II	0.333333	7.335193173422294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.33074978200000005	7.278347907459845
SNEDDON SYNDROME	0.327636771	7.2098442278481985
COWDEN SYNDROME 7; CWS7	0.32614980000000005	7.1771225365416775
CYSTIC FIBROSIS	0.32272730000000005	7.1018083653193935
KABUKI SYNDROME 1	0.32193832299999997	7.0844464518443155
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.32059261000000006	7.054833227798138
CYSTINOSIS, NEPHROPATHIC; CTNS	0.31666809	6.968471804497835
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.31666669999999997	6.968441216711714
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.3125	6.8767504768338785
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.31174240000000003	6.860079033117882
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.3109212	6.842008033144838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.309322372	6.806824861268436
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.30918216	6.803739411867291
#600802 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,B CELL-POSITIVE, NK CELL-NEGATIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-NEGATIVE	0.306705	6.749228015991471
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.305604823	6.725017959321546
#275200 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1;;THYROTROPIN RESISTANCE;;THYROID-STIMULATING HORMONE, RESISTANCE TO; RTSH;;TSH RESISTANCE;;HYPOTHYROIDISM, NONAUTOIMMUNE;;HYPOTHYROIDISM, CONGENITAL, DUE TO TSH RESISTANCE;;HYPOTHYROIDISM DUE TO UNRESPONSIVENESS TO THYROTROPIN	0.3055556	6.723934777597637
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.3040906	6.6916965713622405
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.3014383	6.63333111443518
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.3	6.601680457760523
NIJMEGEN BREAKAGE SYNDROME	0.299417	6.588851192070942
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.29720549999999996	6.540185804296483
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.2916667	6.418301178565004
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.291412342	6.4127038777720875
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.291357352	6.4114937897441795
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.2907434	6.397983406676169
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.28921768999999997	6.364409240372136
Diamond-Blackfan anemia 1	0.2892033	6.36409257976618
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.285157582	6.2750641215721465
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.2844828	6.260215137763317
HURLER SYNDROME	0.280511972	6.172834679067557
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.27413986	6.032612521517352
BARDET-BIEDL SYNDROME 16; BBS16	0.273098342	6.009693291427333
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.27274788	6.001981164305374
#611521 IMMUNODEFICIENCY 35; IMD35;;TYROSINE KINASE 2 DEFICIENCY;;TYK2 DEFICIENCY;;HYPER-IgE SYNDROME WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;;HIES WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE	0.2712584	5.969204260944624
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.269730341	5.935578403482606
MARFAN SYNDROME; MFS	0.2685407	5.9093996376777715
IMMUNODEFICIENCY 16	0.2675439	5.887464454076785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.266468882	5.86380803633565
ARTERIAL TORTUOSITY SYNDROME	0.26573162	5.847584142543485
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.2625	5.776470400540458
FRONTOTEMPORAL DEMENTIA; FTD	0.2625	5.776470400540458
KEUTEL SYNDROME; KTLS	0.261913171	5.763556875402634
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.2608229	5.739564806221424
TUFTSIN DEFICIENCY	0.25900901	5.699649065669666
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.25900901	5.699649065669666
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.2579207	5.675700149473049
%156230 MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE	0.25757610000000003	5.6681170191872345
LEPTIN DEFICIENCY OR DYSFUNCTION	0.2572101	5.6600629690287665
POLYCYSTIC KIDNEYS	0.25680272	5.651098327079158
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.255727633	5.627440390951517
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25534759	5.619077316130822
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25534759	5.619077316130822
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.25469298	5.604672229315972
HAMAMY SYNDROME; HMMS	0.25396799999999997	5.588718608321748
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.252129341	5.548257811025796
CULLER-JONES SYNDROME; CJS	0.252057472	5.546676290449734
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.25121359	5.528106159422881
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.250915751	5.5215520330700185
CEROID STORAGE DISEASE	0.25	5.501400381467103
CLEIDOCRANIAL DYSPLASIA; CCD	0.25	5.501400381467103
#614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;APLAID	0.25	5.501400381467103
HYPERLIPOPROTEINEMIA, TYPE IV	0.25	5.501400381467103
ANEURYSM, INTRACRANIAL BERRY, 2	0.25	5.501400381467103
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	5.501400381467103
HYPEREKPLEXIA 1; HKPX1	0.25	5.501400381467103
FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4	0.25	5.501400381467103
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.25	5.501400381467103
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.25	5.501400381467103
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	5.501400381467103
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	5.501400381467103
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.25	5.501400381467103
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.25	5.501400381467103
ANEURYSM, INTRACRANIAL BERRY, 3	0.25	5.501400381467103
#136580 FRAGILE SITE 16q22; FRA16A	0.25	5.501400381467103
DYSTONIA 6, TORSION	0.25	5.501400381467103
THYROID CARCINOMA, FAMILIAL MEDULLARY	0.25	5.501400381467103
BRACHYDACTYLY, TYPE E	0.25	5.501400381467103
CEPHALIN LIPIDOSIS	0.25	5.501400381467103
ADRENAL HYPOPLASIA, CONGENITAL	0.245	5.39137237383776
IMMUNODEFICIENCY 15A; IMD15A	0.24359010000000003	5.360346676246439
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.24027769999999998	5.287455321752152
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.23795275100000002	5.2362934204901865
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.237037	5.216141768887271
THYROID CANCER, NONMEDULLARY, 4; NMTC4	0.23448280000000002	5.1599350614698976
ATRANSFERRINEMIA	0.23376609999999998	5.144163646856307
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.23376609999999998	5.144163646856307
RHEUMATOID ARTHRITIS	0.2337488	5.14378294994991
#300751 ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA;;ANEMIA, HYPOCHROMIC; ANH1;;ANEMIA, HEREDITARY SIDEROBLASTIC;;HEREDITARY IRON-LOADING ANEMIA	0.23333330000000002	5.1346396225159125
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.23285260000000002	5.124061529862427
KRABBE DISEASE	0.230082751	5.0631093364816016
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.22996843	5.060593634109563
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.227065551	4.996714035557751
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.22670240000000003	4.988722679358031
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	4.938675339807748
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	4.938675339807748
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	4.938675339807748
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	4.938675339807748
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	4.938675339807748
FONTAINE PROGEROID SYNDROME; FPS	0.22305077999999998	4.9083665847141384
DYSCHONDROSTEOSIS AND NEPHRITIS	0.22222260000000002	4.890141985642446
#615561 COMPLEMENT FACTOR B DEFICIENCY; CFBD	0.2222222	4.890133183401836
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.22159092000000002	4.876241487270586
#614380 COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD;;C4A DEFICIENCY	0.22142860000000003	4.872669538030906
SECKEL SYNDROME 10; SCKL10	0.22013602000000002	4.844225537610599
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.22010435000000003	4.843528620210275
KEARNS-SAYRE SYNDROME; KSS	0.219721901	4.835112599912308
TRACHEOBRONCHOMEGALY	0.21960780000000002	4.832601738772605
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.21679005099999998	4.7705954770786905
#615550 DIAMOND-BLACKFAN ANEMIA 12; DBA12	0.216667	4.767887665805331
FIBROSCLEROSIS, MULTIFOCAL	0.21590910000000002	4.751209620408876
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.2142856	4.715483526331628
VICI SYNDROME; VICIS	0.21413762300000005	4.712227203434636
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.21354580099999998	4.699203804328392
STORMORKEN SYNDROME; STRMK	0.21257726999999998	4.677890697076941
#170100 PROLIDASE DEFICIENCY	0.21168547200000004	4.658266145647376
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.21152289	4.654688430940096
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.210768643	4.638090772006014
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.21017501100000002	4.625027542761011
TAY-SACHS DISEASE; TSD	0.21017501100000002	4.625027542761011
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.205874262	4.530386974004233
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.20381679	4.485111065021601
PELIZAEUS-MERZBACHER DISEASE	0.202973223	4.46654786575923
GAUCHER DISEASE, TYPE II	0.20250971299999998	4.456348049395974
MESOMELIA-SYNOSTOSES SYNDROME	0.20238130000000001	4.4535222440872335
RENPENNING SYNDROME 1; RENS1	0.20212934100000002	4.447977734732376
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.20212934100000002	4.447977734732376
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.20192310000000002	4.44343927746808
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.20175963300000002	4.43984208780345
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.20114980000000002	4.426422345808126
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.200915751	4.4212719567765975
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.200915751	4.4212719567765975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.200843882	4.419690436200535
JOUBERT SYNDROME 2	0.200843882	4.419690436200535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	4.419690436200535
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	4.419690436200535
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.200546753	4.413151933824755
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.2	4.4011203051736825
KINDLER SYNDROME; KNDLRS	0.2	4.4011203051736825
AORTIC ANEURYSM, ABDOMINAL	0.2	4.4011203051736825
#610102 COMPLEMENT COMPONENT 7 DEFICIENCY; C7D;;C7 DEFICIENCY	0.2	4.4011203051736825
RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE	0.2	4.4011203051736825
#612446 COMPLEMENT COMPONENT 6 DEFICIENCY; C6D;;C6 DEFICIENCYCOMPLEMENT COMPONENT 6 DEFICIENCY, SUBTOTAL, INCLUDED;;C6 DEFICIENCY, SUBTOTAL, INCLUDED	0.2	4.4011203051736825
REFSUM DISEASE	0.2	4.4011203051736825
THYROID CANCER, NONMEDULLARY, 5; NMTC5	0.2	4.4011203051736825
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.2	4.4011203051736825
THYROID CANCER, NONMEDULLARY, 3; NMTC3	0.2	4.4011203051736825
LOEYS-DIETZ SYNDROME 3; LDS3	0.2	4.4011203051736825
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.198581111	4.3698967992302435
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.19697	4.3344433325503005
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19444430000000001	4.278863784776416
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19444430000000001	4.278863784776416
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19444430000000001	4.278863784776416
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19444430000000001	4.278863784776416
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19444430000000001	4.278863784776416
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19444430000000001	4.278863784776416
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19444430000000001	4.278863784776416
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	4.278198819509506
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.194029382	4.269733264602504
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.193724602	4.26302639736945
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.19202448	4.225614190092088
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.1916667	4.217741025978163
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1916667	4.217741025978163
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.19089426199999998	4.2007430631467235
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.19044052300000003	4.190758263515979
Growth hormone deficiency, isolated, type IA	0.1895236	4.170580821348073
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.18787470100000003	4.134295806997672
PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	0.18742789999999998	4.124463682230312
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.18730659999999996	4.121794402765223
#615961 ACID-LABILE SUBUNIT DEFICIENCY; ACLSD	0.186667	4.107719620029279
#613796 MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE;;STAT1 DEFICIENCY, AUTOSOMAL RECESSIVE	0.18633529999999998	4.100420362003147
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.18548731000000002	4.081759831965227
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.1836162	4.04058493089416
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.183352033	4.034771777155875
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.18333330000000003	4.034359546222492
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	4.008174684866033
POTOCKI-LUPSKI SYNDROME	0.18136012299999998	3.990938599420482
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	3.9896045538391802
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.1807104	3.9766410539802908
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1797414	3.9553176261017247
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.17955474100000002	3.951210082526507
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.17944491	3.94879318530532
ALKAPTONURIA	0.1790112	3.9392491358675357
COMPLEMENT COMPONENT C1R DEFICIENCY	0.1786925	3.932235950661241
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.17867147100000003	3.931773194866754
RETT SYNDROME; RTT	0.17805560099999998	3.9182206050550166
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.1774069	3.9039455493395847
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.176521911	3.884470834050808
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.17502379999999998	3.8515040003432874
ODONTOCHONDRODYSPLASIA; ODCD	0.17466700000000002	3.843652401718858
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.17461375999999998	3.84248082349362
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.17438547100000001	3.8374571867268816
#173100 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2;;IGHD II;;GROWTH HORMONE DEFICIENCY, ISOLATED, AUTOSOMAL DOMINANT;;PITUITARY DWARFISM DUE TO ISOLATED GROWTH HORMONE DEFICIENCY, AUTOSOMALDOMINANT	0.1734317	3.8164688821539525
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.17342376	3.8162941576778375
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.17342376	3.8162941576778375
CHROMOSOME 18Q DELETION SYNDROME	0.17320404099999998	3.8114591089161745
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.17151222099999996	3.774229592142679
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.1704477	3.7508041672007617
MARSHALL-SMITH SYNDROME; MRSHSS	0.16926752	3.724833596391962
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.16842663300000002	3.706329372141679
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.167582751	3.687759241114826
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.167582751	3.687759241114826
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.167582451	3.687752639434368
300270 ADRENOMYODYSTROPHY	0.167510582	3.686171118858305
#249700 LANGER MESOMELIC DYSPLASIA; LMD;;DYSCHONDROSTEOSIS, HOMOZYGOUS;;MESOMELIC DWARFISM OF THE HYPOPLASTIC ULNA, FIBULA, AND MANDIBLE TYPE	0.166667	3.6676075895119107
PEROXISOME BIOGENESIS DISORDER 11B	0.166667	3.6676075895119107
DIAMOND-BLACKFAN ANEMIA 13; DBA13	0.166667	3.6676075895119107
#615592 IMMUNODEFICIENCY 15; IMD15	0.166667	3.6676075895119107
#612359 COWDEN-LIKE SYNDROME	0.166667	3.6676075895119107
CANDIDIASIS, FAMILIAL, 9; CANDF9	0.166667	3.6676075895119107
#613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	0.166667	3.6676075895119107
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.166667	3.6676075895119107
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.166667	3.6676075895119107
NIEVERGELT SYNDROME	0.166667	3.6676075895119107
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.166667	3.6676075895119107
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	0.166667	3.6676075895119107
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.1666666	3.6675987872713
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.165946382	3.651749956951542
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.16460605099999998	3.622255167052773
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.16131198999999996	3.5497673732848694
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.15971079000000002	3.5145320041216497
Fabry disease	0.159475231	3.5093483866318174
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.15927059	3.5048451383299617
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.15496135	3.4100177200106288
PETERS-PLUS SYNDROME; PTRPLS	0.154566223	3.401322712696517
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.1544118	3.397924541692088
COCKAYNE SYNDROME A; CSA	0.15327322100000002	3.3728694259123664
IMMUNODEFICIENCY 52; IMD52	0.15247333000000002	3.355267343302238
KOOLEN-DE VRIES SYNDROME; KDVS	0.15131811299999998	3.329846098324328
OCULOECTODERMAL SYNDROME; OES	0.150289023	3.3072003538500727
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.15	3.3008402288802614
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.149573272	3.2914498225523308
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.149486933	3.2895498809221886
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.149048472	3.279901282871555
HALLERMANN-STREIFF SYNDROME; HSS	0.14876682000000002	3.2737033611905915
MYASTHENIA GRAVIS; MG	0.14824020000000002	3.262114771315039
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.147834251	3.253181619381214
#614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITHOR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY	0.1468397	3.23129592637806
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.146374782	3.221065126127856
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.1462824	3.2190322046476934
BARATELA-SCOTT SYNDROME	0.146173982	3.2166464013414617
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.145238	3.196049554414077
OROFACIODIGITAL SYNDROME VIII; OFD8	0.14491447199999996	3.1889301261636147
OROFACIODIGITAL SYNDROME IX; OFD9	0.14491447199999996	3.1889301261636147
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.14432218200000002	3.1758964284358586
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.144298872	3.17538347786429
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	3.1622243482078356
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.14354070000000002	3.1586994469442202
YOUNG SYNDROME	0.14354070000000002	3.1586994469442202
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.143488751	3.1575562779505524
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.14285699999999998	3.1436542171809827
IMMUNODEFICIENCY 30; IMD30	0.14285699999999998	3.1436542171809827
INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	0.14285699999999998	3.1436542171809827
IMMUNODEFICIENCY 28; IMD28	0.14285699999999998	3.1436542171809827
HAIM-MUNK SYNDROME	0.14285699999999998	3.1436542171809827
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.14285699999999998	3.1436542171809827
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.14285699999999998	3.1436542171809827
PITUITARY DWARFISM IV	0.14285699999999998	3.1436542171809827
PANHYPOPITUITARISM, X-LINKED	0.14285699999999998	3.1436542171809827
ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY; SIDBA2	0.14285699999999998	3.1436542171809827
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.142756542	3.141443578462898
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.1425439	3.136764263343234
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.1422929	3.131240857360241
NIEMANN-PICK DISEASE, TYPE A	0.14200177199999997	3.1248344105992176
TUBEROUS SCLEROSIS 2; TSC2	0.140841151	3.099294247350663
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.13978169000000001	3.0759801707524654
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.13974772000000002	3.075232640468632
CAMPOMELIC DYSPLASIA	0.138756	3.053409245323397
IMMUNODEFICIENCY 58; IMD58	0.13838029	3.045141520774113
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.138074223	3.038406332331895
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.13774539000000002	3.03117016436534
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.13753097	3.0264517232861627
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.13748454000000002	3.0254300032073167
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.13748454000000002	3.0254300032073167
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.13748454000000002	3.0254300032073167
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.13748454000000002	3.0254300032073167
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.13748454000000002	3.0254300032073167
ZUNICH NEUROECTODERMAL SYNDROME	0.13702675099999997	3.01535608089039
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.1363457	3.0003691439655964
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.136016751	2.9931304233492635
CASPASE 8 DEFICIENCY	0.13517819	2.97467738412813
Adrenoleukodystrophy	0.13517501099999998	2.9746074283208785
Myhre syndrome	0.135097251	2.9728962727462274
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.134924761	2.9691005265390307
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	2.958091982314098
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.13400901	2.9489488749361152
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.133915751	2.9468966545434143
KLEEFSTRA SYNDROME	0.133915751	2.9468966545434143
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.133	2.9267450029404984
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.1324787	2.9152734828650635
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	2.9152734828650635
HYPER-IGD SYNDROME	0.1320994	2.9069267582063016
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.13135027199999996	2.89044174594643
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.13068182	2.875732057595261
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.13068182	2.875732057595261
HARDIKAR SYNDROME	0.13067229000000002	2.87552234421272
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.1299997	2.8607215966824353
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.12939065	2.8473190850731056
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.1293848	2.847190352304179
FANCONI-LIKE SYNDROME	0.1286549	2.8311284637504475
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.12849059999999998	2.8275129434197472
OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS	0.12806019999999999	2.8180417325230134
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.12798521	2.8163915324645887
INCONTINENTIA PIGMENTI; IP	0.127129341	2.7975576202922454
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	2.7708518423364668
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.125915751	2.7708518423364668
ACTH DEFICIENCY, ISOLATED; IAD	0.125915751	2.7708518423364668
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125843882	2.7692703217604038
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125843882	2.7692703217604038
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	2.7670701577086447
PROPROTEIN CONVERTASE 1/3 DEFICIENCY	0.125	2.7507001907335513
#607398 GLUCOCORTICOID DEFICIENCY 2; GCCD2;;FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2	0.125	2.7507001907335513
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1	0.125	2.7507001907335513
DIVERTICULOSIS, SMALL-INTESTINAL	0.125	2.7507001907335513
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	0.125	2.7507001907335513
ACRORENAL SYNDROME	0.125	2.7507001907335513
#221900 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE	0.125	2.7507001907335513
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.125	2.7507001907335513
Glucocorticoid deficiency 5	0.125	2.7507001907335513
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.125	2.7507001907335513
AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3	0.125	2.7507001907335513
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.12498799000000001	2.750435903459226
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.12461882	2.742312095543921
OCULORENOCEREBELLAR SYNDROME	0.1242424	2.7340287470175535
MEIER-GORLIN SYNDROME 1; MGORS1	0.12418709000000001	2.7328116171971577
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.12354978000000001	2.7187872272887064
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.123066182	2.7081453624019995
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.12260233300000001	2.6979380861398274
MEHMO SYNDROME; MEHMO	0.12233433300000003	2.692040584930895
#100800 ACHONDROPLASIA; ACH	0.1222481	2.690142975894514
#614420 SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16	0.1222223	2.6895752313751466
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.12182340000000001	2.680797196926478
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.1212121	2.6673451727137145
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.12081397200000002	2.658584126589424
SHORT SYNDROME	0.12048339000000002	2.651309470825799
ADAMS-OLIVER SYNDROME 1; AOS1	0.12043205300000003	2.6501797692602658
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.12032479	2.647819382423796
TYROSINEMIA, TYPE I; TYRSN1	0.12032090000000001	2.647733780633861
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.12032090000000001	2.647733780633861
OMODYSPLASIA 1; OMOD1	0.1202501	2.6461757840458286
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.1201911	2.644877453555803
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.12012000999999999	2.6433130753433285
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.12012000999999999	2.6433130753433285
WHITE-SUTTON SYNDROME; WHSUS	0.11960137200000001	2.6319001341791557
EMPHYSEMA, HEREDITARY PULMONARY	0.1192983	2.625230852513507
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.11929705100000002	2.625203367517202
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.11916681300000001	2.6223374019856758
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.11885049200000002	2.6153765681054115
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.11871164199999999	2.6123210903335443
PULMONARY HEMOSIDEROSIS	0.11805560000000001	2.597884491497311
ALAGILLE SYNDROME 2	0.11791371999999999	2.59476233675282
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.1178161	2.5926141499318653
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.1178161	2.5926141499318653
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.11720822300000001	2.579237450893125
GAUCHER DISEASE, PERINATAL LETHAL	0.117037421	2.5754788501413035
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.11688310000000002	2.5720829237082303
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.11679302000000001	2.57010065912278
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.11650715100000002	2.5638099398201817
MAJEED SYNDROME	0.11645858999999999	2.5627413258044833
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.11614137999999999	2.5557609289444625
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.11612551100000001	2.555411722053849
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.1160902	2.554634682258369
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.115843541	2.5492068025915993
GOODPASTURE SYNDROME	0.1149069	2.5285954539728093
BLOOM SYNDROME	0.11391779	2.5068294934475572
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.11354012000000001	2.4985186379192825
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.11337984100000001	2.494991602112318
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.1133639	2.494640810818394
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.112870633	2.4837861737705333
PARANA HARD-SKIN SYNDROME	0.11263740000000001	2.478653741309851
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.11232458999999999	2.4717701690965432
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.11232458999999999	2.4717701690965432
CRANIOECTODERMAL DYSPLASIA 3	0.11232458999999999	2.4717701690965432
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.11232458999999999	2.4717701690965432
AORTIC VALVE DISEASE 3; AOVD3	0.1117424	2.4589587279441982
MEIER-GORLIN SYNDROME 6; MGORS6	0.1112063	2.4471615249661802
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.11111120000000001	2.44506879226107
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.11111120000000001	2.44506879226107
Ullrich congenital muscular dystrophy 1	0.11111099999999999	2.445064391140765
ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO	0.11111099999999999	2.445064391140765
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.11111099999999999	2.445064391140765
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.11111099999999999	2.445064391140765
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.11111099999999999	2.445064391140765
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.11111099999999999	2.445064391140765
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.11111099999999999	2.445064391140765
603529 DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLASTHETEROCHROMATIN	0.11111099999999999	2.445064391140765
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.11111099999999999	2.445064391140765
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.11111099999999999	2.445064391140765
CHILBLAIN LUPUS 1	0.11111099999999999	2.445064391140765
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11111099999999999	2.445064391140765
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.1107372	2.436838697290395
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.1107372	2.436838697290395
CILIARY DYSKINESIA, PRIMARY, 27; CILD27	0.1107372	2.436838697290395
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.1107372	2.436838697290395
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.1107372	2.436838697290395
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.1107372	2.436838697290395
#614874 CILIARY DYSKINESIA, PRIMARY, 18; CILD18;;CILIARY DYSKINESIA, PRIMARY, 18, WITH OR WITHOUT SITUS INVERSUS	0.1107372	2.436838697290395
PRADER-WILLI SYNDROME; PWS	0.11071462300000001	2.436341876824746
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.11064119000000001	2.434725939487897
#156550 KNIEST DYSPLASIA	0.1100428	2.421558007590832
MEIER-GORLIN SYNDROME 3; MGORS3	0.10987739000000002	2.417918061042439
SECKEL SYNDROME 1; SCKL1	0.10930054100000001	2.4052241518078428
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.10920890200000001	2.403207580489614
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.10879626	2.3941271450647768
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.10818720000000001	2.380724413399431
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	2.37899697367965
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.10800000000000001	2.3766049647937884
IMMUNODEFICIENCY 57; IMD57	0.10800000000000001	2.3766049647937884
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.1074495	2.364490881153798
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.10714290000000001	2.3577439637259667
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.10713982300000002	2.3576762524900716
LIDDLE SYNDROME 1; LIDLS1	0.10680272	2.3502580981988968
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.10680272	2.3502580981988968
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.10622407200000002	2.337524600887156
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.1058007	2.328208045357946
REVESZ SYNDROME	0.10567077200000001	2.325348901562893
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.10534759	2.3182370872505595
#610600 CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;;CMO II DEFICIENCY;;ALDOSTERONE DEFICIENCY II;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1B;;ALDOSTERONE DEFICIENCY DUE TO DEFICIENCY OF STEROID 18-OXIDASE;;STEROID 18-OXIDASE DEFICIENCY;;18-@OXIDASE DEFICIENCY	0.10534759	2.3182370872505595
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.10534759	2.3182370872505595
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.10530018199999999	2.317193845693421
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.10450183300000002	2.299625695720846
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.10446858	2.298893943453306
#612692 AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT	0.1043084	2.2953690862008926
IMMUNODEFICIENCY 10; IMD10	0.10428472999999999	2.294848213612775
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.10424240000000001	2.2939167165001857
STORM SYNDROME	0.10416660000000001	2.2922486919045246
AORTIC VALVE DISEASE 1; AOVD1	0.10416660000000001	2.2922486919045246
IMMUNODEFICIENCY 60; IMD60	0.1037296	2.28263224403772
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.10369457200000001	2.281861431827472
NOONAN SYNDROME 2; NS2	0.10357257200000002	2.279176748441316
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.10330309	2.2732466349309215
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.10324549999999999	2.271979332339047
NOONAN SYNDROME 10; NS10	0.10272869000000001	2.2606066174144632
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.10212934100000001	2.2474175821455353
MCLEOD SYNDROME; MCLDS	0.10192310000000002	2.242879124881239
HYPOADRENOCORTICISM, FAMILIAL	0.10187725100000002	2.241870190056879
GAUCHER DISEASE, TYPE IIIC	0.10179295100000002	2.240015117848249
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.10152861	2.234198135135299
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.10123942000000002	2.2278343352300336
OSTEOGENESIS IMPERFECTA, TYPE X	0.10121359	2.22726593054262
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.10055038100000001	2.2126716175602503
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.10038804100000001	2.2090992282085407
IRON-REFRACTORY IRON DEFICIENCY ANEMIA	0.1	2.2005601525868412
#300448 ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS;;HEMOGLOBIN H DISEASE, ACQUIRED	0.1	2.2005601525868412
BETA-THALASSEMIA	0.1	2.2005601525868412
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	2.2005601525868412
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	2.2005601525868412
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	2.2005601525868412
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	2.2005601525868412
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	2.2005601525868412
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	2.2005601525868412
#604131 ALPHA-THALASSEMIA	0.1	2.2005601525868412
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.099537	2.190371559080364
WEILL-MARCHESANI SYNDROME 1; WMS1	0.09896999000000001	2.1778941629591815
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.09809497200000002	2.158638865523219
WEILL-MARCHESANI SYNDROME 2; WMS2	0.09775640000000001	2.151188385003403
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.09771182	2.1502073752873794
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.09769911300000002	2.149927750108791
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.09738560000000002	2.143028707957611
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.0969828	2.1341648516629905
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.09696969999999999	2.133876578283002
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.09696969999999999	2.133876578283002
#608647 CILIARY DYSKINESIA, PRIMARY, 5; CILD5;;CILIARY DYSKINESIA, PRIMARY, 5, WITHOUT SITUS INVERSUS	0.0967021	2.12798787931468
THYROCEREBRORETINAL SYNDROME	0.09663597100000001	2.126532670891376
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	2.1265087067913138
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.09661282300000003	2.126023285227255
274210 THYMIC APLASIA WITH FETAL DEATH	0.0964286	2.121969347297355
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0961679	2.116232486979561
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.09579100000000002	2.1079385757644613
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.09522269	2.0954325723612945
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.09477807	2.0856484418108634
AICARDI-GOUTIERES SYNDROME 7	0.09459154300000003	2.0815438029750477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.094246682	2.073954929227235
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.09407212	2.070113587413676
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.09405962000000001	2.069838517394603
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.09388232300000002	2.0659369902608713
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.09347830000000001	2.0570462211155855
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.093202402	2.050974919665801
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.09306209	2.0478872697045034
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.092803	2.042185838405166
OGDEN SYNDROME; OGDNS	0.09259608200000001	2.037632483348637
CHROMOSOME 17q12 DELETION SYNDROME	0.09248349000000002	2.035154828661636
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.09216269	2.0280954316921376
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.09215680000000001	2.0279658186991503
EHLERS-DANLOS SYNDROME, TYPE I	0.09212269000000001	2.027215207631103
#613501 AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79A DEFECT	0.0918904	2.022103526452659
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	2.0206610812782397
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.09175298200000001	2.019079560702177
GLYCOGEN STORAGE DISEASE II	0.0913333	2.0098442058425974
CILIARY DYSKINESIA DUE TO TRANSPOSITION OF CILIARY MICROTUBULES	0.0909091	2.0005094296753243
RCAD (renal cysts and diabetes)	0.0909091	2.0005094296753243
#151210 PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT;;LETHAL SHORT-LIMBED PLATYSPONDYLIC DWARFISM, TORRANCE TYPE;;THANATOPHORIC DYSPLASIA, TORRANCE VARIANTPLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, LUTON TYPE, INCLUDED; PLSDL,INCLUDED;;THANATOPHORIC DYSPLASIA, LUTON VARIANT, INCLUDED	0.0909091	2.0005094296753243
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.0909091	2.0005094296753243
ELLIS-VAN CREVELD SYNDROME	0.0909091	2.0005094296753243
CILIARY DYSKINESIA, PRIMARY, 34; CILD34	0.0909091	2.0005094296753243
Contractural arachnodactyly, congenital	0.0909091	2.0005094296753243
MARFANOID HABITUS WITH SITUS INVERSUS	0.0909091	2.0005094296753243
NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE	0.0909091	2.0005094296753243
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	2.0005094296753243
191400 ULNA AND FIBULA, HYPOPLASIA OF;;MESOMELIC DWARFISM OF HYPOPLASTIC ULNA AND FIBULA TYPE;;REINHARDT-PFEIFFER MESOMELIC DYSPLASIA	0.0909091	2.0005094296753243
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.09088376000000001	1.9999518077326588
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.09052516100000002	1.9920606210310838
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.09025640000000001	1.9861463735593898
POLYCYSTIC KIDNEY DISEASE 3	0.09013602000000001	1.9834973392477058
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.09010249	1.982759491428543
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0900384	1.9813491524267504
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.0900384	1.9813491524267504
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0899471	1.9793400410074387
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.08986930000000001	1.9776280052087263
LICHTENSTEIN SYNDROME	0.08981831	1.9765059395869218
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	1.9745967556041393
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.089581041	1.9712846925184806
FAMILIAL MEDITERRANEAN FEVER; FMF	0.089527	1.9700954878064212
MASP2 DEFICIENCY	0.089394	1.9671687428034805
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.0889029	1.956361791894127
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.0888889	1.956053713472765
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.0888889	1.956053713472765
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	1.9544451040012234
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.08868089000000001	1.9514763282993688
CILIARY DYSKINESIA, PRIMARY, 33	0.0881794	1.940440739190161
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.087982772	1.9361138217733325
PELGER-HUET ANOMALY; PHA	0.087839702	1.9329654803630265
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.08767572000000001	1.9293569578136118
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.0874872	1.9252084618139549
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.08722762300000002	1.9194963137866747
MEIER-GORLIN SYNDROME 5; MGORS5	0.08715009000000001	1.9177901534835697
MEIER-GORLIN SYNDROME 2; MGORS2	0.08715009000000001	1.9177901534835697
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.0871146	1.917009174685416
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0867412	1.9087922830756572
MYXEDEMA	0.0864452	1.9022786250239998
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.086339941	1.8999623374129886
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.08552519	1.8820332515641858
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0852273	1.875478002925645
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.0847619	1.8652365959755057
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.08465467	1.8628769353238868
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.08454689000000001	1.8605051715914291
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.08454689000000001	1.8605051715914291
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08424905100000002	1.853951045238566
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08424905100000002	1.853951045238566
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0842391	1.8537320674977815
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.08412700000000001	1.851265239566732
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.08385746	1.845333849731449
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.08371311300000002	1.842157407167995
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0837036	1.841948067880679
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.08333330000000001	1.8337993936356503
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.08333330000000001	1.8337993936356503
ANEURYSM, INTRACRANIAL BERRY, 1	0.08333330000000001	1.8337993936356503
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.08333330000000001	1.8337993936356503
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.08333330000000001	1.8337993936356503
MEESTER-LOEYS SYNDROME; MRLS	0.08333330000000001	1.8337993936356503
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.08333330000000001	1.8337993936356503
#603373 HYPERTHYROIDISM, FAMILIAL GESTATIONAL	0.08333330000000001	1.8337993936356503
CHILBLAIN LUPUS 2; CHBL2	0.08333330000000001	1.8337993936356503
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.08333330000000001	1.8337993936356503
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.0833205	1.833517721936119
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.08303899000000001	1.8273229250505718
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.0827957	1.8219691822553432
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.08271528200000001	1.820199535791836
NEPHROSIALIDOSIS	0.0823529	1.8122251018996887
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.08211529	1.8069963509211269
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.08210780000000001	1.8068315289656984
MUCOLIPIDOSIS IV; ML4	0.082012682	1.8047384001597606
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.08085305100000001	1.7792200224567165
PSEUDOTRISOMY 13 SYNDROME	0.0806818	1.7754515411898097
OSTEOGENESIS IMPERFECTA, TYPE I	0.0805556	1.7726744342772456
MARFANOID HYPERMOBILITY SYNDROME	0.0805556	1.7726744342772456
COACH SYNDROME	0.07992724300000001	1.7588470605192554
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.07983527200000001	1.75682318334132
EOSINOPHILOPENIA	0.0791926	1.7426807993974867
GAUCHER DISEASE, TYPE I	0.0791203	1.7410897944071666
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.07905244100000001	1.739596516293223
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	1.7355575861835633
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.07870369999999999	1.7319222608114895
DUBOWITZ SYNDROME	0.07848240000000001	1.727052421193815
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.07832069	1.7234938953710668
GLYCOGEN STORAGE DISEASE IB	0.07826411	1.722248818436733
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.07823132000000001	1.7215272547626999
SCALP-EAR-NIPPLE SYNDROME; SENS	0.07823132000000001	1.7215272547626999
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.07823132000000001	1.7215272547626999
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.07814459	1.7196187089423614
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	1.7191876192084696
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.07785320000000001	1.7132064967137386
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.07783885100000001	1.7128907383374443
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.07783885100000001	1.7128907383374443
LISSENCEPHALY 2; LIS2	0.07776698200000001	1.7113092177613816
CHROMOSOME 16p13.3 DELETION SYNDROME	0.077435343	1.7040113020769438
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.07711042000000001	1.6968611760123542
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.07711042000000001	1.6968611760123542
TRANSALDOLASE DEFICIENCY	0.07698107	1.6940147514549828
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.07694659	1.693255998314371
SHORT STATURE WITH NONSPECIFIC SKELETAL ABNORMALITIES	0.07692310000000001	1.6927390867345287
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	1.6927390867345287
12q14 microdeletion syndrome	0.07692310000000001	1.6927390867345287
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.07692310000000001	1.6927390867345287
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.07692310000000001	1.6927390867345287
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.07692310000000001	1.6927390867345287
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.07692310000000001	1.6927390867345287
CANAVAN DISEASE	0.07692310000000001	1.6927390867345287
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.07692310000000001	1.6927390867345287
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.07692310000000001	1.6927390867345287
MYOCLONUS AND ATAXIA	0.07692310000000001	1.6927390867345287
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.076591461	1.6854411710500907
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.07656809	1.68492687813683
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.07638890000000001	1.6809836943994096
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.076358482	1.6803143280121957
KAPUR-TORIELLO SYNDROME	0.07616114100000002	1.6759717206014795
MORQUIO SYNDROME A	0.0761495	1.6757155533941166
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0761495	1.6757155533941166
BARDET-BIEDL SYNDROME 12; BBS12	0.07610066	1.674640799815593
#613652 C1q DEFICIENCY; C1QD	0.07567571	1.6652895194471753
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.0755556	1.6626464266479033
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.075268562	1.656329982797121
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.07524539000000001	1.6558200689985636
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.074989851	1.6501967795902448
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0748538	1.6472028954970488
#312863 COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX;;XCID;;IMMUNODEFICIENCY 6; IMD6	0.0748538	1.6472028954970488
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.074760941	1.6451594773449583
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	1.6377338851604677
BARDET-BIEDL SYNDROME 1; BBS1	0.074313302	1.63530891188352
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0740741	1.6300451279873291
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.0738215	1.6244865130418946
AORTIC VALVE DISEASE 2; AOVD2	0.07373740000000001	1.6226358419535694
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.07332061000000001	1.613464127293603
IMMUNODEFICIENCY 49; IMD49	0.07318823300000002	1.6105510917804131
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.072676152	1.5992824413454443
BIEMOND SYNDROME II	0.07264219000000001	1.5985350871064234
NAIL-PATELLA SYNDROME	0.07264219000000001	1.5985350871064234
PYGMY	0.07264219000000001	1.5985350871064234
ROIFMAN SYNDROME; RFMN	0.072356362	1.592245270033487
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.0719697	1.5837365401362917
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.07142860000000001	1.5718293091506446
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.07142860000000001	1.5718293091506446
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.07142860000000001	1.5718293091506446
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.07142860000000001	1.5718293091506446
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.07142860000000001	1.5718293091506446
#614432 VENTRICULAR SEPTAL DEFECT 3; VSD3	0.07142860000000001	1.5718293091506446
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.07142860000000001	1.5718293091506446
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.07142860000000001	1.5718293091506446
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.07142860000000001	1.5718293091506446
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.07142860000000001	1.5718293091506446
MECKEL SYNDROME, TYPE 5	0.07142860000000001	1.5718293091506446
#614809 CFHR5 DEFICIENCY	0.07142860000000001	1.5718293091506446
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.07136100000000001	1.570341730487496
OVARIAN HYPERSTIMULATION SYNDROME	0.07107849999999999	1.5641251480564375
GLYCEROL KINASE DEFICIENCY; GKD	0.07082081300000001	1.5584545906160416
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.07076866100000001	1.5573069544852647
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.07068698000000001	1.55550951494703
MUCOPOLYSACCHARIDOSIS, TYPE II	0.07054785100000001	1.5524478976123375
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	1.5461465716098033
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.07022002000000001	1.5452337792585105
#613494 IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4;;ANTIBODY DEFICIENCY DUE TO BAFFR DEFECT	0.0701063	1.5427313022529885
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.0695994	1.531576662839526
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.06930789	1.5251618099387199
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.069225282	1.523343971207871
MYELOPEROXIDASE DEFICIENCY	0.06904760000000001	1.5194339719175518
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.0688889	1.5159416829553964
IMMUNODEFICIENCY 36; IMD36	0.06882089000000001	1.5144450819956223
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.06880909	1.514185415897617
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.068724172	1.512316744227243
SCLEROSTEOSIS 1; SOST1	0.06821006	1.501003400415576
IVIC SYNDROME	0.06818182	1.5003819622284853
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.06818182	1.5003819622284853
MEGALOBLASTIC ANEMIA 1	0.06808276	1.498202087341333
ALPORT SYNDROME, X-LINKED; ATS	0.06804014	1.4972642086043002
MENTAL RETARDATION, X-LINKED 98; MRX98	0.06791592299999999	1.4945307387995612
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.06788029	1.49374661320039
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.06777896	1.491516785597774
CD8 DEFICIENCY, FAMILIAL	0.06760730000000001	1.4877393040398434
DYSOSTEOSCLEROSIS	0.067582451	1.487192486847527
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.067510582	1.4856109662714645
LETTERER-SIWE DISEASE	0.06735568	1.4822022545839044
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.06734	1.4818572067519786
CURRARINO SYNDROME	0.06686118199999999	1.4713205286405653
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.0667978	1.469925769604653
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.066728952	1.4684107279507999
BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3	0.0666667	1.4670408352446116
#613790 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1;;C8 DEFICIENCY, TYPE I;;C8 ALPHA-GAMMA DEFICIENCY;;C8AG DEFICIENCY	0.0666667	1.4670408352446116
BARDET-BIEDL SYNDROME 11; BBS11	0.0666667	1.4670408352446116
#211400 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1;;CYSTIC FIBROSIS-LIKE SYNDROME	0.0666667	1.4670408352446116
KYPHOMELIC DYSPLASIA	0.0666667	1.4670408352446116
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.0666667	1.4670408352446116
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.0666667	1.4670408352446116
#613021 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2;;CYSTIC FIBROSIS-LIKE SYNDROME	0.0666667	1.4670408352446116
COMPLEMENT COMPONENT 2 DEFICIENCY	0.0666667	1.4670408352446116
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.0666667	1.4670408352446116
NIPPLES, SUPERNUMERARY	0.0666667	1.4670408352446116
COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF	0.0666667	1.4670408352446116
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.0666667	1.4670408352446116
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	1.4670408352446116
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.066572351	1.4649646287462474
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.06631679	1.459340855214695
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.06599112	1.4521742909657653
RETINAL VENOUS BEADING	0.0658649	1.4493967439411704
ROIFMAN-CHITAYAT SYNDROME	0.065718082	1.4461659255363453
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.06565660000000001	1.444812977143332
Aarskog-Scott syndrome	0.065535772	1.4421540843221643
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0654885	1.4411138355268334
#613193 CILIARY DYSKINESIA, PRIMARY, 13; CILD13;;CILIARY DYSKINESIA, PRIMARY, 13, WITH OR WITHOUT SITUS INVERSUS	0.0654521	1.4403128316312919
Bangstad syndrome	0.06536	1.4382861157307592
EOSINOPHILIA, FAMILIAL	0.06507018	1.4319084522965324
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.06498956	1.4301343607015167
#615468 IMMUNODEFICIENCY 12; IMD12	0.06495489	1.4293714264966146
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.06439399999999999	1.4170287046567702
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0643224	1.4154531035875182
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.06425963300000001	1.4140718779965442
FORMIMINOTRANSFERASE DEFICIENCY	0.06417109	1.4121234360206392
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	1.4119454107042948
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.06394552	1.407159632484449
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.06371359	1.4020558733225543
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.0635556	1.3985792083374824
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.06343116	1.3958408312836033
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.063415751	1.3955017469696913
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.063343882	1.3939202263936286
HYDROXYKYNURENINURIA	0.063343882	1.3939202263936286
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	1.3917200623418693
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	1.3917200623418693
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.063	1.38635289612971
#300752 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP;;PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT; XLDPP;;ERYTHROHEPATIC PROTOPORPHYRIA, X-LINKED;	0.0625	1.3753500953667757
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.0625	1.3753500953667757
#613956 CANDIDIASIS, FAMILIAL, 6; CANDF6;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0625	1.3753500953667757
IMMUNODEFICIENCY 62; IMD62	0.0625	1.3753500953667757
PERRY SYNDROME	0.0625	1.3753500953667757
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0625	1.3753500953667757
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0625	1.3753500953667757
#613743 ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIALOR COMPLETE;;P450SCC DEFICIENCY	0.0625	1.3753500953667757
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.0625	1.3753500953667757
GASTROINTESTINAL ULCERATION, RECURRENT, WITH DYSFUNCTIONAL PLATELETS; GURDP	0.0625	1.3753500953667757
PEUTZ-JEGHERS SYNDROME	0.0625	1.3753500953667757
PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A	0.0625	1.3753500953667757
LYMPHOKINE DEFICIENCY	0.0625	1.3753500953667757
PROTOPORPHYRIA, ERYTHROPOIETIC, 2; EPP2	0.0625	1.3753500953667757
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0625	1.3753500953667757
MONOCYTE CHEMOTACTIC DISORDER	0.0625	1.3753500953667757
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.0625	1.3753500953667757
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0625	1.3753500953667757
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.0625	1.3753500953667757
FASCIAL DYSTROPHY, CONGENITAL	0.0625	1.3753500953667757
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.0625	1.3753500953667757
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.0625	1.3753500953667757
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.0625	1.3753500953667757
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.0625	1.3753500953667757
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.0625	1.3753500953667757
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.0625	1.3753500953667757
#172700 PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS	0.0625	1.3753500953667757
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.0625	1.3753500953667757
AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS22	0.0625	1.3753500953667757
BREATH-HOLDING SPELLS	0.0625	1.3753500953667757
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	0.0625	1.3753500953667757
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.06249999999999999	1.3753500953667754
GRISCELLI SYNDROME, TYPE 2; GS2	0.062499251	1.3753336131712328
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.06235832	1.3722323417425906
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.06235832	1.3722323417425906
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.06235832	1.3722323417425906
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.06235832	1.3722323417425906
CHARGE SYNDROME	0.0622678	1.370240394692469
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.062037	1.3651615018602987
#613502 AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO BLNK DEFECT	0.061986099999999995	1.3640414167426318
DIAMOND-BLACKFAN ANEMIA 8	0.061522890000000004	1.3538482020598346
DIAMOND-BLACKFAN ANEMIA 4	0.061522890000000004	1.3538482020598346
FECHTNER SYNDROME	0.06123742	1.3475662629922447
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.06122166	1.347219454712197
PREPAPILLARY VASCULAR LOOPS	0.0611888	1.346496350646057
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.061051209999999995	1.3434685999321125
OSTEOGENESIS IMPERFECTA, TYPE V	0.06097789	1.3418551492282362
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0608777	1.3396504080113594
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.060714300000000006	1.3360546927220325
MUSCULAR HYPERTONIA, LETHAL	0.06068370000000001	1.3353813213153412
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0606295	1.334188617712639
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.06059257	1.3333759508482885
#150250 LARSEN SYNDROME; LRS	0.060585980000000005	1.333230933934233
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.060583133	1.3331682839866887
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.060583133	1.3331682839866887
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.060583133	1.3331682839866887
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.060398551	1.329106446045841
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.060398551	1.329106446045841
SILVER-RUSSELL SYNDROME; SRS	0.060363572	1.3283367121100675
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.060216272	1.3250952870053072
#613493 IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3;;ANTIBODY DEFICIENCY DUE TO CD19 DEFECT	0.0601995	1.3247262090565153
LESCH-NYHAN SYNDROME; LNS	0.06003709	1.321152279312699
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.059893152	1.3179848370402685
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	1.3179066731436488
IMMUNE DEFICIENCY DISEASE	0.0596073	1.311694491832896
MYELOLYMPHATIC INSUFFICIENCY	0.0596073	1.311694491832896
YUNIS-VARON SYNDROME	0.059138890000000006	1.3013868480221642
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.05904927	1.2994147060134158
FANCONI ANEMIA	0.05904927	1.2994147060134158
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.05904927	1.2994147060134158
PERNICIOUS ANEMIA	0.0588235	1.2944465013569206
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0587761	1.2934034358445943
HYPERLYSINEMIA, TYPE I	0.05877317099999999	1.2933389814377247
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.058770991999999994	1.293291031232
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.058593603	1.2893874795829279
INFANTILE LIVER FAILURE SYNDROME 1	0.058516393	1.2876884270891156
#202700 NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	0.05819506	1.2806173011340036
DIAMOND-BLACKFAN ANEMIA 10	0.057970350000000004	1.275672422415126
TEMTAMY SYNDROME; TEMTYS	0.057315233	1.2612561787603034
CRANIOECTODERMAL DYSPLASIA 4	0.05727419	1.2603530028568772
BLEPHAROCHALASIS AND DOUBLE LIP	0.0572101	1.2589426638550842
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05714280000000001	1.2574616868723936
STIFF-PERSON SYNDROME; SPS	0.05703778	1.2551506586001469
OPSISMODYSPLASIA; OPSMD	0.0568215	1.2503912871021319
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.056769190000000004	1.249240174086314
CRANIOFACIOFRONTODIGITAL SYNDROME	0.056769190000000004	1.249240174086314
PRIMROSE SYNDROME; PRIMS	0.056769190000000004	1.249240174086314
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.056769190000000004	1.249240174086314
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.056705000000000005	1.2478276345243682
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.056705000000000005	1.2478276345243682
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	1.24654470795541
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.0566448	1.246502897312511
SPINOCEREBELLAR ATAXIA 14	0.0566448	1.246502897312511
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.056471351	1.2426860477334507
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.056399482	1.241104527157388
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	1.241104527157388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.056171433	1.2360861717350153
WITTEVEEN-KOLK SYNDROME	0.05593191300000001	1.2308153900575391
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.05579449	1.2277913142790498
FACIOCARDIOMELIC SYNDROME	0.055555600000000004	1.222534396130535
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	1.222534396130535
#604308 MASS SYNDROME;;MASS PHENOTYPE;;OVERLAP CONNECTIVE TISSUE DISEASE; OCTD	0.055555600000000004	1.222534396130535
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3	0.055555600000000004	1.222534396130535
IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS	0.055555600000000004	1.222534396130535
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	1.222534396130535
#613780 AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7;;AORTIC DISSECTION, FAMILIAL, WITH OR WITHOUT AORTIC ANEURYSM	0.055555600000000004	1.222534396130535
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	1.222534396130535
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.055555600000000004	1.222534396130535
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	1.222534396130535
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	1.222534396130535
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.055555600000000004	1.222534396130535
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.055555600000000004	1.222534396130535
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.055555600000000004	1.222534396130535
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.055555600000000004	1.222534396130535
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.055555600000000004	1.222534396130535
#609135 APLASTIC ANEMIA;;APLASTIC ANEMIA, SUSCEPTIBILITY TO, INCLUDED	0.055555600000000004	1.222534396130535
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4	0.055555600000000004	1.222534396130535
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.055555600000000004	1.222534396130535
THORACOLARYNGOPELVIC DYSPLASIA	0.055555600000000004	1.222534396130535
CHLORAMPHENICOL TOXICITY	0.055555600000000004	1.222534396130535
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.055555600000000004	1.222534396130535
THYROID DYSHORMONOGENESIS 6; TDH6	0.055555600000000004	1.222534396130535
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0555555	1.2225321955703825
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.05537898	1.2186477667890363
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.05534759	1.2179570109571392
IMMUNODEFICIENCY 55; IMD55	0.05528299	1.216535449098568
SPONDYLOCOSTAL DYSOSTOSIS 5	0.05499999999999999	1.2103080839227625
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.05498248	1.2099225457840292
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.05475579	1.2049340959741301
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.05475579	1.2049340959741301
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.05475579	1.2049340959741301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.054727762	1.2043173229745632
#176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1;;DEMENTIA, FAMILIAL BRITISH; FBD;;PRESENILE DEMENTIA WITH SPASTIC ATAXIA;;CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE	0.05471376	1.204009200541998
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.054582200000000004	1.2011141436052548
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	1.2011141436052548
ROWLEY-ROSENBERG SYNDROME	0.05448541	1.198984221433566
GLYCOGEN STORAGE DISEASE IV	0.054411799999999996	1.1973643891052468
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.05416929000000001	1.1920278106792086
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.05416929000000001	1.1920278106792086
IMMUNODEFICIENCY 50; IMD50	0.054023600000000005	1.1888218145929048
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.053997199999999995	1.1882408667126216
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.05391009	1.1863239587637033
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.05387418199999999	1.1855337816241123
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.05381679	1.1842708361413399
#615207 IL21R IMMUNODEFICIENCY	0.0534722	1.1766879259115408
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.053219233000000005	1.1711212349103466
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.052958261	1.1653783890689375
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.052941100000000005	1.1650007509411522
ACETOPHENETIDIN SENSITIVITY	0.0526635	1.158891995957571
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.0526316	1.1581900172688957
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.0526316	1.1581900172688957
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0526316	1.1581900172688957
242680 CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA;;IMMOTILE CILIA SYNDROME DUE TO EXCESSIVELY LONG CILIA	0.0526316	1.1581900172688957
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.0526316	1.1581900172688957
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.0526316	1.1581900172688957
RETICULOENDOTHELIOSIS, X-LINKED	0.05259006	1.1572759045815113
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.05248731	1.1550148290247282
MECKEL SYNDROME, TYPE 1; MKS1	0.052301589999999995	1.150927948709344
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.052057472	1.1455559852760522
DIAMOND-BLACKFAN ANEMIA 5	0.052057472	1.1455559852760522
CHROMOSOME 15q25 DELETION SYNDROME	0.052057472	1.1455559852760522
GLYCOGEN STORAGE DISEASE IA	0.05182581	1.1404581236153664
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.05176906	1.1392093057287733
IMMUNODEFICIENCY 22; IMD22	0.051478300000000005	1.1328109570291118
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.051358262	1.1301694486331497
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.051226251	1.1272644671701182
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.051136299999999996	1.1252850413072648
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.051126	1.1250583836115482
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.050966933	1.121558018593633
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.05073761	1.1165116280349163
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.050599033	1.113462157792266
Oliver-McFarlane syndrome	0.0505747	1.112926695490337
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.05038459	1.1087432105842543
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0503105	1.1071128155672028
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	1.1068296694923694
JOHANSON-BLIZZARD SYNDROME; JBS	0.050258779999999996	1.1059746858562847
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.050115172	1.102814505432358
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	1.1012193193777478
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.05	1.1002800762934206
DIAMOND-BLACKFAN ANEMIA 3	0.05	1.1002800762934206
EVEN-PLUS SYNDROME	0.049891482	1.0978920724270365
COHEN SYNDROME	0.049680040999999994	1.0932391860348052
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.049666699999999994	1.0929456093048484
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.049601872	1.0915190301691295
SECKEL SYNDROME 9; SCKL9	0.049588562	1.0912261356128203
XFE PROGEROID SYNDROME; XFEPS	0.04954781999999999	1.0903295833954532
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0494082	1.0872571613104116
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.049235830999999994	1.0834640777809992
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.04916012	1.0817980116838741
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.04906931999999999	1.0797999030653251
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.048640199999999995	1.0703568593385444
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	1.0681078868626008
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	1.0681078868626008
CAMURATI-ENGELMANN DISEASE	0.04849586	1.067180570814301
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.04847239	1.0666640993464886
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.048093511000000005	1.0583266390459694
CYCLIC VOMITING SYNDROME	0.047955400999999995	1.0552874454192314
#300867 KABUKI SYNDROME 2; KABUK2	0.047893313	1.0539211616316932
TRICHOHEPATOENTERIC SYNDROME 1	0.04779764	1.051815819716909
DK PHOCOMELIA SYNDROME	0.04734851999999999	1.041932663959611
EMANUEL SYNDROME	0.047230223	1.0393294673159055
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.047214133	1.0389753971873539
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.047214133	1.0389753971873539
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.047214133	1.0389753971873539
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.047214133	1.0389753971873539
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.047214133	1.0389753971873539
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.047212011	1.0389287013009163
ALZHEIMER DISEASE 3; AD	0.047212011	1.0389287013009163
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.047206472	1.0388068122740644
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.047138	1.0373000447263852
NATHALIE SYNDROME	0.04701428999999999	1.0345777317616198
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.0466666	1.0269266041670908
TRIMETHYLAMINURIA	0.04659608	1.0253747691474864
LYMPHEDEMA, HEREDITARY, III	0.046394672	1.0209426649553643
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.046370251	1.0204052661605012
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.046370251	1.0204052661605012
DIAPHANOSPONDYLODYSOSTOSIS	0.04632737199999999	1.0194616879726732
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.04629626	1.0187770496980006
ALZHEIMER DISEASE 4	0.04629626	1.0187770496980006
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.04629626	1.0187770496980006
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.04629626	1.0187770496980006
ALZHEIMER DISEASE 10	0.04629626	1.0187770496980006
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.04629626	1.0187770496980006
CREUTZFELDT-JAKOB DISEASE; CJD	0.04629626	1.0187770496980006
HYPOPHOSPHATASIA, INFANTILE	0.045975511	1.0117187750141798
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.0458333	1.0085893364155847
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.04579739	1.0077991152647907
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.045607641000000004	1.0036235743808586
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.04546228	1.000424818137457
KOSAKI OVERGROWTH SYNDROME; KOGS	0.0454545	1.0002536145575855
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.045091962	0.9922757477916004
WIDOW&#39;S PEAK SYNDROME	0.044691890000000005	0.9834719227779433
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0446078	0.9816214717456329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.044567913	0.9807437343175706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.044437033	0.9778636411898649
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.04433719999999999	0.9756667559727327
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.044322182	0.9753362758490175
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.044322182	0.9753362758490175
HEMOCHROMATOSIS, TYPE 3; HFE3	0.044093059999999996	0.9702943084162073
CILIARY DYSKINESIA, PRIMARY, 41; CILD41	0.0440705	0.9697978620457838
IMMUNODEFICIENCY 20; IMD20	0.0440705	0.9697978620457838
#612444 CILIARY DYSKINESIA, PRIMARY, 9; CILD9;;CILIARY DYSKINESIA, PRIMARY, 9, WITH OR WITHOUT SITUS INVERSUS	0.0440705	0.9697978620457838
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.0439613	0.9673948503591591
DESBUQUOIS DYSPLASIA 1	0.043636299999999996	0.9602430298632516
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.043636299999999996	0.9602430298632516
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.043636299999999996	0.9602430298632516
HYPERCALCEMIA, INFANTILE, 1	0.0435606	0.9585772058277434
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.043478300000000004	0.9567661448221645
Immunodeficiency 24	0.043478300000000004	0.9567661448221645
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.043478300000000004	0.9567661448221645
#300853 IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUSINFECTION, AND NEOPLASIA; XMEN	0.043478300000000004	0.9567661448221645
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.043478300000000004	0.9567661448221645
#156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS;;SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE	0.043478300000000004	0.9567661448221645
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.043478300000000004	0.9567661448221645
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.043478300000000004	0.9567661448221645
DIGITOTALAR DYSMORPHISM	0.043478300000000004	0.9567661448221645
ALOPECIA AREATA 1	0.043478300000000004	0.9567661448221645
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.043478300000000004	0.9567661448221645
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.043478300000000004	0.9567661448221645
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.043478300000000004	0.9567661448221645
BRACHYDACTYLY, MONONEN TYPE	0.043478300000000004	0.9567661448221645
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.043478300000000004	0.9567661448221645
%120050 COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S;;CB3S	0.043478300000000004	0.9567661448221645
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.043478300000000004	0.9567661448221645
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.043478300000000004	0.9567661448221645
WEYERS ACROFACIAL DYSOSTOSIS	0.043478300000000004	0.9567661448221645
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.043478300000000004	0.9567661448221645
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0432773	0.9523430189154649
PROPIONIC ACIDEMIA	0.043265003	0.9520724160335013
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.043162790000000006	0.9498231574847379
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.043123499999999995	0.9489585574007862
BEEMER LETHAL MALFORMATION SYNDROME	0.04283352	0.9425773730703151
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.04278617	0.9415354078380652
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.042784682000000004	0.9415026635029948
RITSCHER-SCHINZEL SYNDROME 1	0.042735372	0.9404175672917542
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.042607810999999995	0.9376105107555127
VISCERAL STEATOSIS, CONGENITAL	0.04258245099999999	0.9370524487008166
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.04253594199999999	0.9360289901794501
POLYCYSTIC KIDNEY DISEASE 2	0.04251702	0.9356126001873778
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.04251702	0.9356126001873778
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.04245939	0.9343444173714419
TRACHEOPATHIA OSTEOPLASTICA	0.0423351	0.9316093411577917
ACRORENAL-MANDIBULAR SYNDROME	0.04227829	0.9303592029351073
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.042163633	0.9278361066809557
METHYLMALONIC ACIDURIA, CBLA TYPE	0.042051413	0.9253666380777228
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.041960302	0.9233616857170992
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.04190577200000001	0.9221617202658939
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	0.9212773151405691
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	0.9212773151405691
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.041666699999999994	0.9169007970979013
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.041666699999999994	0.9169007970979013
GALACTORRHEA	0.041666699999999994	0.9169007970979013
TESTICULAR TORSION	0.041666699999999994	0.9169007970979013
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.041666699999999994	0.9169007970979013
URINARY BLADDER, ATONY OF	0.041666699999999994	0.9169007970979013
PEYRONIE DISEASE	0.041666699999999994	0.9169007970979013
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.041666699999999994	0.9169007970979013
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.041666699999999994	0.9169007970979013
SMITH-MCCORT DYSPLASIA 2; SMC2	0.041666699999999994	0.9169007970979013
GENITOURINARY TRACT ANOMALIES	0.041666699999999994	0.9169007970979013
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.041666699999999994	0.9169007970979013
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.041666699999999994	0.9169007970979013
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.041666699999999994	0.9169007970979013
207620 APHALANGY WITH HEMIVERTEBRAE	0.041666699999999994	0.9169007970979013
#226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMYLOSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIACUTIS CONGENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	0.041666699999999994	0.9169007970979013
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.041666699999999994	0.9169007970979013
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.041666699999999994	0.9169007970979013
FRYNS MICROPHTHALMIA SYNDROME	0.041666699999999994	0.9169007970979013
ADENOMYOSIS	0.041666699999999994	0.9169007970979013
LABIA MINORA, INCOMPLETE ADHESION OF	0.041666699999999994	0.9169007970979013
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.041666699999999994	0.9169007970979013
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.041666699999999994	0.9169007970979013
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.041666699999999994	0.9169007970979013
FLOATING-HARBOR SYNDROME	0.04164985	0.9165300027121905
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0415952	0.9153273965888017
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.041517359999999996	0.913614480566028
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.041517359999999996	0.913614480566028
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.041440000000000005	0.9119121272319871
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.041356961	0.9100848040868803
METHYLMALONIC ACIDURIA, CBLB TYPE	0.041135662	0.9052149864748072
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.041061890000000004	0.9035915892390408
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.040895390000000004	0.8999276565849837
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.040871531	0.8994026249381781
PSEUDODIASTROPHIC DYSPLASIA	0.04086081	0.8991667028842191
MELNICK-NEEDLES SYNDROME	0.0404283	0.8896490601682658
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.04013602	0.8832172629542852
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.04013602	0.8832172629542852
AMYLOIDOSIS, FAMILIAL VISCERAL	0.04013602	0.8832172629542852
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.039800962	0.8758441101182306
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.03976486	0.8750496638919436
WATSON SYNDROME	0.03967509	0.8730742210429666
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.039319582000000006	0.8652510536557082
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.039312009999999994	0.865084427240954
#610852 CILIARY DYSKINESIA, PRIMARY, 6; CILD6	0.03925	0.8637198598903351
OROFACIODIGITAL SYNDROME I; OFD1	0.039235060999999995	0.86339111820914
HYPOPLASTIC LEFT HEART SYNDROME	0.0390151	0.8585507440919085
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4	0.0390151	0.8585507440919085
LIG4 SYNDROME	0.038995002	0.8581084755124417
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.038909723	0.8562318598199172
#613500 AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGLL1 DEFECT	0.038856299999999996	0.8550562545696007
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.0386883	0.8513593135132549
THUMBS, CONGENITAL CLASPED	0.0384757	0.8466809226288553
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0384757	0.8466809226288553
ATROPHODERMA VERMICULATA; AVA	0.0384615	0.8463684430871878
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	0.8463684430871878
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	0.8463684430871878
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	0.8463684430871878
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	0.8463684430871878
THUMB DEFORMITY	0.0384615	0.8463684430871878
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	0.8463684430871878
BETHLEM MYOPATHY 1	0.0384615	0.8463684430871878
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	0.8463684430871878
ARTERIES, ANOMALIES OF	0.0384615	0.8463684430871878
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	0.8463684430871878
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	0.8463684430871878
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.038354331	0.844010124777262
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.03830102	0.8428369841543165
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.03825059	0.8417272416693669
#307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR;;HYPOPHOSPHATEMIA, X-LINKED; XLH;;HYP;;VITAMIN D-RESISTANT RICKETS, X-LINKED;;HYPOPHOSPHATEMIC VITAMIN D-RESISTANT RICKETS; HPDR	0.03825059	0.8417272416693669
PYCNODYSOSTOSIS	0.03825059	0.8417272416693669
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.037952751	0.835173115316504
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.037952751	0.835173115316504
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.037898623	0.8339819961171117
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.037843641000000004	0.8327720841340165
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	0.03783066	0.8324864294206091
AMYLOIDOSIS VI	0.03783066	0.8324864294206091
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.03783066	0.8324864294206091
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.037543900000000005	0.8261761031270511
611961 STEVENSON-CAREY SYNDROME	0.037473933	0.8246364372050906
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.037410223	0.8232344603318774
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.03736898	0.8223268833081462
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.037355402	0.8220280912506279
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.037037	0.8150214637135883
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.037037	0.8150214637135883
MOEBIUS SYNDROME; MBS	0.037037	0.8150214637135883
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.037037	0.8150214637135883
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.037037	0.8150214637135883
SPINOCEREBELLAR ATAXIA 27; SCA27	0.037037	0.8150214637135883
WERNICKE-KORSAKOFF SYNDROME	0.037037	0.8150214637135883
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.037037	0.8150214637135883
EXSTROPHY OF BLADDER	0.037037	0.8150214637135883
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.037037	0.8150214637135883
OSTEOARTHRITIS	0.037037	0.8150214637135883
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.036990382	0.8139956065816554
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.036948431	0.8130724495920436
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	0.8126250537074211
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	0.8126250537074211
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.036927890000000005	0.8126204325311008
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.036761390000000005	0.8089564998770439
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.036630051000000004	0.8060663061782377
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.036630051000000004	0.8060663061782377
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.036558182	0.8044847856021751
JOUBERT SYNDROME 35; JBTS35	0.036558182	0.8044847856021751
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.036540272	0.8040906652788468
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.036494472	0.803082808728962
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.036076682	0.7938890884674693
PSEUDO-TORCH SYNDROME 2	0.036009371	0.7924078694231615
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	0.7859146545753223
UROFACIAL SYNDROME 2	0.035714300000000004	0.7859146545753223
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.035714300000000004	0.7859146545753223
BLUE DIAPER SYNDROME	0.035714300000000004	0.7859146545753223
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.035714300000000004	0.7859146545753223
CHANARIN-DORFMAN SYNDROME	0.035714300000000004	0.7859146545753223
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.035714300000000004	0.7859146545753223
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	0.7859146545753223
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.035714300000000004	0.7859146545753223
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	0.7859146545753223
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.035714300000000004	0.7859146545753223
GASTRIC SNEEZING	0.035714300000000004	0.7859146545753223
GIANT NEUTROPHIL LEUKOCYTES	0.035714300000000004	0.7859146545753223
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.035714300000000004	0.7859146545753223
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.035714300000000004	0.7859146545753223
SULFHEMOGLOBINEMIA, CONGENITAL	0.035714300000000004	0.7859146545753223
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	0.7859146545753223
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.035714300000000004	0.7859146545753223
219400 CYANOSIS AND HEPATIC DISEASE	0.035714300000000004	0.7859146545753223
COUMARIN RESISTANCE	0.035714300000000004	0.7859146545753223
GALLBLADDER, AGENESIS OF	0.035714300000000004	0.7859146545753223
UROFACIAL SYNDROME	0.035714300000000004	0.7859146545753223
MACROCYTOSIS, FAMILIAL	0.035714300000000004	0.7859146545753223
109820 BLADDER DIVERTICULUM	0.035714300000000004	0.7859146545753223
HEMOPOIETIC PROLIFERATION	0.035714300000000004	0.7859146545753223
VESICOURETERAL REFLUX 8; VUR8	0.035714300000000004	0.7859146545753223
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	0.7859146545753223
METHANE PRODUCTION	0.035714300000000004	0.7859146545753223
TERATOMA, PINEAL	0.035714300000000004	0.7859146545753223
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.035714300000000004	0.7859146545753223
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.035714300000000004	0.7859146545753223
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.035714300000000004	0.7859146545753223
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.035714300000000004	0.7859146545753223
MYELOMA, MULTIPLE	0.035714300000000004	0.7859146545753223
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	0.7859146545753223
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	0.7859146545753223
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.035714300000000004	0.7859146545753223
FLOOD FACTOR DEFICIENCY	0.035714300000000004	0.7859146545753223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.035675141	0.7850529372251707
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.03552413	0.7817298493331478
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.03545939	0.7803052066903631
NAVAJO NEUROHEPATOPATHY	0.035390772	0.778795226324861
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.03537412	0.7784287890482523
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.035326682	0.777384887323068
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.035307240999999996	0.7769570764238036
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.0352328	0.7753189574406165
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.035189899999999996	0.7743749171351567
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.035031513	0.7708895159262791
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.035031513	0.7708895159262791
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.03477307	0.7652023222511292
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.034546890000000004	0.7602250952980083
LARYNGEAL WEB, FAMILIAL	0.0344828	0.7588147562962153
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0344828	0.7588147562962153
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	0.7573817955360537
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.034417682	0.7573817955360537
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0343137	0.7550936090781909
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.03425322	0.7537627102979063
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.034224272	0.7531256921449355
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.03422427199999999	0.7531256921449353
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.034177182	0.7520894483690823
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.034177182	0.7520894483690823
ACROCALLOSAL SYNDROME; ACLS	0.033908241	0.7461712398891138
BARAITSER-WINTER SYNDROME 1; BRWS1	0.033907523	0.7461554398672182
CATEL-MANZKE SYNDROME; CATMANS	0.033859222999999994	0.7450925693135186
CORNELIA DE LANGE SYNDROME 1	0.033850151	0.7448929344964762
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.03368289	0.7412122555796579
IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	0.0336729	0.7409924196204144
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	0.7388116645092009
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.033536790000000004	0.7379972371967285
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.0333333	0.7335193173422296
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	0.7335193173422296
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	0.7335193173422296
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0333333	0.7335193173422296
%614227 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3	0.0333333	0.7335193173422296
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	0.7335193173422296
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	0.7335193173422296
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.0333333	0.7335193173422296
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	0.7335193173422296
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	0.7335193173422296
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	0.7335193173422296
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	0.7335193173422296
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	0.7335193173422296
BLOOD GROUP, DUFFY SYSTEM; FY	0.0333333	0.7335193173422296
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0333333	0.7335193173422296
IMMUNE SUPPRESSION	0.0333333	0.7335193173422296
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0333333	0.7335193173422296
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	0.7335193173422296
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.0333333	0.7335193173422296
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.0333333	0.7335193173422296
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0333333	0.7335193173422296
ECHO VIRUS 11 SENSITIVITY	0.0333333	0.7335193173422296
RAGWEED SENSITIVITY	0.0333333	0.7335193173422296
DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY	0.0333333	0.7335193173422296
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	0.7335193173422296
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.033228589999999995	0.7312151108064556
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.033228589999999995	0.7312151108064556
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.033228589999999995	0.7312151108064556
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.033173851	0.7300105461845312
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.033173851	0.7300105461845312
EPISODIC ATAXIA, TYPE 6	0.033173851	0.7300105461845312
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.03297035	0.7255323842684156
DE SANCTIS-CACCHIONE SYNDROME	0.0329411	0.7248887204237839
MEGAEPIPHYSEAL DWARFISM	0.0329411	0.7248887204237839
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.03288426	0.7236379220330535
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.032767551	0.7210696702845709
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.03260077199999999	0.7173995980676879
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.032507272	0.7153420743250194
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.032500042	0.7151829738259874
#612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11	0.03246359	0.7143808256391665
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.032441453	0.7138936876381884
GRACILE BONE DYSPLASIA; GCLEB	0.032385023	0.7126519115440835
CINCA SYNDROME; CINCA	0.03237459	0.7124223271033643
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.032305572000000005	0.7109035444972519
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.0322581	0.7098588945816158
PEROXISOME BIOGENESIS DISORDER 14B	0.0322581	0.7098588945816158
EPISODIC ATAXIA, TYPE 2	0.0322581	0.7098588945816158
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0322581	0.7098588945816158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.032191241	0.7083876220691978
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.03216126	0.7077278721298507
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.03204638	0.7051998686265589
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.032024712999999996	0.7047230732582979
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.032003072	0.7042468500356767
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.0318518	0.7009180186816554
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.031809500000000004	0.6999871817371113
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03180272	0.6998379837587658
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.03175676	0.6988266063126369
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.03175676	0.6988266063126369
NEURAMINIDASE DEFICIENCY	0.031541140999999995	0.6940817805172306
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.0314409	0.6918759170146761
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.031418162	0.6913755536471808
LATHOSTEROLOSIS	0.031263341	0.6879686244133445
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.03125	0.6876750476833878
#612518 CILIARY DYSKINESIA, PRIMARY, 10; CILD10	0.03125	0.6876750476833878
CILIARY DYSKINESIA, PRIMARY, 25; CILD25	0.03125	0.6876750476833878
CILIARY DYSKINESIA, PRIMARY, 24; CILD24	0.03125	0.6876750476833878
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE III; CDG3	0.03125	0.6876750476833878
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.031218750999999996	0.6869873946413059
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.031218750999999996	0.6869873946413059
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.031218750999999996	0.6869873946413059
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.03119607	0.6864882855930977
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.031174781999999998	0.686019830347815
INFANTILE SIALIC ACID STORAGE DISEASE	0.031171433	0.6859461335883049
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.031146881999999997	0.6854058740652432
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.031146881999999997	0.6854058740652432
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.031071192000000004	0.6837402700857504
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.03100304	0.6822405443305594
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.030681820000000002	0.67517190500842
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.03062539	0.6739301289143151
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.030612220000000002	0.6736403151422196
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.030612220000000002	0.6736403151422196
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.030599513000000002	0.6733606899636303
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.030576423000000002	0.672852580624398
#245590 GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY;;LARON SYNDROME DUE TO POSTRECEPTOR DEFECT;;GROWTH HORMONE INSENSITIVITY DUE TO POSTRECEPTOR DEFECT	0.0305747	0.6728146649729688
#613092 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2;;EARLY-ONSET HYPERURICEMIA, ANEMIA, AND PROGRESSIVE KIDNEY FAILURE	0.03056626	0.6726289376960906
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.030331033	0.6674526260659651
CITRULLINEMIA, CLASSIC	0.030331033	0.6674526260659651
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.030331033	0.6674526260659651
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.030331033	0.6674526260659651
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.030331033	0.6674526260659651
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	0.6674496993209622
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	0.6674496993209622
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.030327550999999998	0.667376002561452
VASCULAR HYALINOSIS	0.030302999999999997	0.6668357430383903
Osteogenesis imperfecta, type IX	0.030302999999999997	0.6668357430383903
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.030302999999999997	0.6668357430383903
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.030302999999999997	0.6668357430383903
SCHNECKENBECKEN DYSPLASIA	0.030302999999999997	0.6668357430383903
THORACOMELIC DYSPLASIA	0.030302999999999997	0.6668357430383903
LERI-WEILL DYSCHONDROSTEOSIS	0.030302999999999997	0.6668357430383903
SENIOR-LOKEN SYNDROME 8; SLSN8	0.030302999999999997	0.6668357430383903
CAROLI DISEASE, ISOLATED	0.030302999999999997	0.6668357430383903
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.030302999999999997	0.6668357430383903
CHEILITIS GLANDULARIS	0.030302999999999997	0.6668357430383903
CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	0.030302999999999997	0.6668357430383903
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.030302999999999997	0.6668357430383903
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.030302999999999997	0.6668357430383903
#200700 CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY	0.030302999999999997	0.6668357430383903
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.030302999999999997	0.6668357430383903
Leri-Weill dyschondrostosis (LWD) - SHOX deletion	0.030302999999999997	0.6668357430383903
DUANE-RADIAL RAY SYNDROME; DRRS	0.030302999999999997	0.6668357430383903
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.030302999999999997	0.6668357430383903
TELANGIECTASIA, HEREDITARY BENIGN	0.030302999999999997	0.6668357430383903
#608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED;;SEMD, MATN3-RELATED	0.030302999999999997	0.6668357430383903
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.030302999999999997	0.6668357430383903
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.030302999999999997	0.6668357430383903
IMMUNODEFICIENCY 32B; IMD32B	0.0302222	0.6650576904351003
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0302222	0.6650576904351003
#615206 CARD11 IMMUNODEFICIENCY	0.0302222	0.6650576904351003
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.03004689	0.6611998884316003
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.02998248	0.659782507637319
IMMUNODEFICIENCY 32A	0.029842309999999997	0.6566979824714381
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.029842309999999997	0.6566979824714381
COFFIN-SIRIS SYNDROME 2; CSS2	0.029526133000000003	0.6497403173977937
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.029487151	0.6488824950391122
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.0294118	0.6472243509585365
HEMOCHROMATOSIS, TYPE 1	0.0294118	0.6472243509585365
SPLENOPORTAL VASCULAR ANOMALIES	0.0294118	0.6472243509585365
Mental retardation, autosomal dominant 21	0.029248282	0.6436260390082296
Helsmoortel-van der Aa syndrome	0.029223633	0.6430836229362185
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.02886706	0.635237019583335
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02886706	0.635237019583335
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.02886706	0.635237019583335
HURLER-SCHEIE SYNDROME	0.028821390000000002	0.6342320237616486
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.028804701000000002	0.6338647722777834
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.028737493000000003	0.6323858198104328
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.02857331	0.6287728741351111
DERMOGRAPHISM, FAMILIAL	0.0285714	0.6287308434361967
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	0.6287308434361967
STROKE, ISCHEMIC	0.0285714	0.6287308434361967
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	0.6287308434361967
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	0.6287308434361967
CARDIOMYOPATHY, DILATED, 1E	0.0285714	0.6287308434361967
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	0.6287308434361967
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.028555990000000003	0.6283917371166832
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.028555990000000003	0.6283917371166832
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.028541820000000002	0.6280799177430616
SEA-BLUE HISTIOCYTE DISEASE	0.02840912	0.6251597744205788
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.028404399999999996	0.6250559079813766
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.028197932999999994	0.6205124774511351
GLUTATHIONE SYNTHETASE DEFICIENCY	0.028174250999999997	0.6199913407957995
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.028132541999999996	0.6190735091617571
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.028095469999999997	0.6182577175019901
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.028074889999999998	0.6178048422225878
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.028074889999999998	0.6178048422225878
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.027930572	0.6146290378215775
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.02762411	0.6078851571667568
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.027623313	0.6078676187023407
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.027607800000000002	0.6075262458058699
COPPER DEFICIENCY, FAMILIAL BENIGN	0.027280311	0.6003196533677648
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.027254402000000004	0.5997495102378312
MENTAL RETARDATION, X-LINKED 41	0.027159682	0.5976651396613009
HAREL-YOON SYNDROME; HAYOS	0.027159682	0.5976651396613009
#613217 DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5;;ENTEROPATHY, CONGENITAL TUFTING; CTE;;INTESTINAL EPITHELIAL CELL DYSPLASIA	0.027027	0.5947453924396455
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.027027	0.5947453924396455
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.027027	0.5947453924396455
HEMOCHROMATOSIS, TYPE 2A	0.027027	0.5947453924396455
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.027027	0.5947453924396455
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.027027	0.5947453924396455
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.027027	0.5947453924396455
Yao syndrome	0.027027	0.5947453924396455
VERTICAL TALUS, CONGENITAL	0.027027	0.5947453924396455
PSORIASIS 1, SUSCEPTIBILITY TO	0.027027	0.5947453924396455
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.027027	0.5947453924396455
DIGEORGE SYNDROME; DGS	0.026907633	0.5921186498023072
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.026759633	0.5888618207764788
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.026488700999999996	0.582899799143872
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.026488700999999996	0.582899799143872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.026468541999999998	0.5824561882227121
#300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX;;XLN	0.026438299999999998	0.5817906948213668
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.026438299999999998	0.5817906948213668
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.026425533	0.5815097493066861
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.026425532999999994	0.5815097493066859
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.02641052	0.5811793792109782
CIRRHOSIS, FAMILIAL	0.02641052	0.5811793792109782
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.02641052	0.5811793792109782
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.02641052	0.5811793792109782
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.02641052	0.5811793792109782
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.02641052	0.5811793792109782
THROMBOCYTHEMIA, ESSENTIAL	0.02641052	0.5811793792109782
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.02641052	0.5811793792109782
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.02640578	0.5810750726597456
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.026324973	0.5792968660172447
MYOCLONIC-ATONIC EPILEPSY	0.0263158	0.5790950086344478
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	0.5790950086344478
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	0.5790950086344478
SAUL-WILSON SYNDROME; SWILS	0.026284562	0.5784075976539829
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.026213590000000002	0.576845816102489
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.026213590000000002	0.576845816102489
WILSON DISEASE	0.026208460000000003	0.5767329273666613
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.026165102	0.5757788084957025
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.02602049	0.5725965344478438
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.025915751	0.5702916897496257
MAPLE SYRUP URINE DISEASE; MSUD	0.025915751	0.5702916897496257
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.025866972000000002	0.5692182785127955
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025843882000000002	0.5687101691735632
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.025800010999999998	0.5677447614290217
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.025700523	0.5655554681444162
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.025670619999999998	0.564897434641988
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.025569133	0.5626641521599324
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.025514250000000002	0.5614564187313881
THROMBOCYTOPENIA 3	0.025289620000000002	0.5565133004606323
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0252414	0.5554521903550549
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.025216411	0.554902292378525
SMITH-KINGSMORE SYNDROME; SKS	0.025116071	0.5526942503214194
RING CHROMOSOME 14 SYNDROME	0.025059372	0.5514465547205041
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.02502309	0.5506481474859426
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.02502309	0.5506481474859426
HOOFT DISEASE	0.025	0.5501400381467103
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.025	0.5501400381467103
CZECH DYSPLASIA, METATARSAL TYPE	0.025	0.5501400381467103
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.5501400381467103
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.025	0.5501400381467103
#219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;;CYSTINOSIS, INTERMEDIATE	0.025	0.5501400381467103
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.025	0.5501400381467103
NEUTROPHILIA, HEREDITARY	0.025	0.5501400381467103
BENT BONE DYSPLASIA SYNDROME; BBDS	0.025	0.5501400381467103
HYPERLIPOPROTEINEMIA, TYPE I	0.025	0.5501400381467103
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.5501400381467103
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.025	0.5501400381467103
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.025	0.5501400381467103
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	0.5501400381467103
ANDROGEN INSENSITIVITY SYNDROME	0.025	0.5501400381467103
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.5501400381467103
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.5501400381467103
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.025	0.5501400381467103
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.5501400381467103
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.024985353000000002	0.5498177221011609
COFFIN-SIRIS SYNDROME 1; CSS1	0.024891013000000003	0.5477417136532106
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.02488426	0.5475931098261062
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.024725251	0.5440940211330794
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.024653382	0.5425125005570168
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.024507512999999998	0.5393025654680399
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.024507512999999995	0.5393025654680398
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.024486933	0.5388496901886375
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.024468882	0.5384524670754941
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.024468882	0.5384524670754941
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.024373271999999998	0.5363485115136057
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.024340341	0.5356238450497575
COFFIN-SIRIS SYNDROME 3; CSS3	0.024333913000000002	0.5354823930431493
COFFIN-SIRIS SYNDROME 4; CSS4	0.024333913000000002	0.5354823930431493
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.02413986	0.5312121400502497
#613495 IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5;;ANTIBODY DEFICIENCY DUE TO CD20 DEFECT	0.024128999999999998	0.5309731592176788
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.02410508	0.5304467852291802
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.024056062	0.5293681146535851
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	0.5277346608579214
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.02396516	0.5273677614636806
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.02396147	0.5272865607940501
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.02394089	0.5268336855146477
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.023844610000000002	0.5247149861997372
#614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	0.0238095	0.5239423695301639
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 8; FSGS8	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 18; NPHS18	0.0238095	0.5239423695301639
#600995 NEPHROTIC SYNDROME, TYPE 2; NPHS2;;NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE; SRN1	0.0238095	0.5239423695301639
#612551 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4;;END-STAGE RENAL DISEASE, NONDIABETIC, SUSCEPTIBILITY TO, INCLUDED	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 4	0.0238095	0.5239423695301639
#614131 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 19; NPHS19	0.0238095	0.5239423695301639
#610725 NEPHROTIC SYNDROME, TYPE 3; NPHS3;;NEPHROTIC SYNDROME, EARLY-ONSET, TYPE 3	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 12	0.0238095	0.5239423695301639
#614196 NEPHROTIC SYNDROME, TYPE 6; NPHS6	0.0238095	0.5239423695301639
#613237 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 5	0.0238095	0.5239423695301639
FRASIER SYNDROME	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 13	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.0238095	0.5239423695301639
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7; FSGS7	0.0238095	0.5239423695301639
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 9; FSGS9	0.0238095	0.5239423695301639
NEPHROTIC SYNDROME, TYPE 20; NPHS20	0.0238095	0.5239423695301639
MEND SYNDROME; MEND	0.023806523	0.5238768588544214
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.023735372	0.5223111383002543
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.023643050999999998	0.5202795591617846
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.023643050999999998	0.5202795591617846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.023528572	0.5177603799047048
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.023528572	0.5177603799047048
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.02343579	0.5157186561839316
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.023251041	0.511653143307629
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.02321218	0.5107979836267321
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.023137951	0.5091645298310685
TENORIO SYNDROME; TNORS	0.023137951	0.5091645298310685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	0.5075830092550059
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	0.5075830092550059
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	0.5075830092550059
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.022973223	0.5055395911029154
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.02295269	0.5050877500867846
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0229268	0.5045180250632799
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.02289149	0.5037410072734015
FRANK-TER HAAR SYNDROME; FTHS	0.02289149	0.5037410072734015
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.022890772	0.5037252072515059
THROMBOCYTOPENIA 5; THC5	0.022747879999999998	0.5005807828382715
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0227273	0.500127907558869
STICKLER SYNDROME, TYPE III	0.0227273	0.500127907558869
EHLERS-DANLOS SYNDROME, TYPE VI	0.0227273	0.500127907558869
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0227273	0.500127907558869
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0227273	0.500127907558869
IMINOGLYCINURIA	0.0227273	0.500127907558869
UNIQUE GREEN PHENOMENON	0.0227273	0.500127907558869
DERMOIDS OF CORNEA	0.0227273	0.500127907558869
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0227273	0.500127907558869
MYELINATED OPTIC NERVE FIBERS	0.0227273	0.500127907558869
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0227273	0.500127907558869
MELKERSSON-ROSENTHAL SYNDROME	0.0227273	0.500127907558869
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0227273	0.500127907558869
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0227273	0.500127907558869
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0227273	0.500127907558869
MELANOMA, CUTANEOUS MALIGNANT	0.0227273	0.500127907558869
PUPIL, EGG-SHAPED	0.0227273	0.500127907558869
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0227273	0.500127907558869
AGNATHIA-OTOCEPHALY COMPLEX	0.0227273	0.500127907558869
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0227273	0.500127907558869
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0227273	0.500127907558869
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0227273	0.500127907558869
611426 TENTED EYEBROWS	0.0227273	0.500127907558869
#184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2	0.0227273	0.500127907558869
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0227273	0.500127907558869
OCULAR CICATRICIAL PEMPHIGOID	0.0227273	0.500127907558869
PARIETAL FORAMINA	0.022654851	0.4985336237339215
PAPILLOMA OF CHOROID PLEXUS	0.022654851	0.4985336237339215
CRANIOSYNOSTOSIS 2	0.022654851	0.4985336237339215
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.022654851	0.4985336237339215
NEUROFIBROMATOSIS, TYPE II	0.022654851	0.4985336237339215
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.022654851	0.4985336237339215
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.02263102	0.49800920824395856
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.022592933	0.4971710808986427
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.02233529	0.49150149170471347
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.02233529	0.49150149170471347
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.022320471999999997	0.4911754127013031
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.02229679	0.4906542760459675
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.022276441	0.4902064840605176
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	0.489012878228153
MENTAL RETARDATION, X-LINKED 77	0.0222222	0.489012878228153
#253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C;;MUSCULAR DYSTROPHY, DUCHENNE-LIKE;;DUCHENNE-LIKE MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, TYPE 1; DMDA1;;DMDA;;ADHALIN DEFICIENCY, SECONDARY;;SARCOGLYCAN, GAMMA, DEFICIENCY OF;;SEVERE CHILDHOOD AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, NORTH AFRICANTYPE; SCARMD;;MAGHREBIAN MYOPATHY	0.0222222	0.489012878228153
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	0.489012878228153
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	0.489012878228153
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	0.489012878228153
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.0222222	0.489012878228153
215030 CHOLESTEROL PNEUMONIA	0.0222222	0.489012878228153
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	0.489012878228153
EPILEPSY, HOT WATER, 1	0.0222222	0.489012878228153
TARP SYNDROME; TARPS	0.022204572000000002	0.48862496348445505
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.022129341	0.48696946007606234
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.022129341	0.48696946007606234
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.022057472	0.48538793949999975
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.022057472	0.48538793949999975
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.022057472	0.48538793949999975
TEEBI-SHALTOUT SYNDROME; TBSH	0.02204689	0.48515507622465304
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.02204689	0.48515507622465304
WEILL-MARCHESANI SYNDROME 3	0.02204689	0.48515507622465304
MCDONOUGH SYNDROME	0.02204689	0.48515507622465304
PFEIFFER-PALM-TELLER SYNDROME	0.02204689	0.48515507622465304
Williams-Beuren Syndrome (WBS)	0.02204689	0.48515507622465304
MUCOLIPIDOSIS III GAMMA	0.02204689	0.48515507622465304
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.021816472	0.4800845895322654
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.0217391	0.4783819721310059
EPISODIC ATAXIA, TYPE 3	0.0217391	0.4783819721310059
MARSILI SYNDROME; MARSIS	0.0217391	0.4783819721310059
EPISODIC ATAXIA, TYPE 1; EA1	0.0217391	0.4783819721310059
#613882 HYPOMAGNESEMIA 6, RENAL; HOMG6	0.0217391	0.4783819721310059
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.0217391	0.4783819721310059
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0217391	0.4783819721310059
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0217391	0.4783819721310059
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0217391	0.4783819721310059
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0217391	0.4783819721310059
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0217391	0.4783819721310059
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0217391	0.4783819721310059
CHIARI MALFORMATION TYPE I	0.0217391	0.4783819721310059
GLUTAMATE MONOSODIUM SENSITIVITY	0.0217391	0.4783819721310059
BRUNNER SYNDROME; BRNRS	0.0217391	0.4783819721310059
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.02168216	0.477128973180123
POPOV-CHANG SYNDROME; POPCHAS	0.021680692	0.4770966689570831
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.021665272000000003	0.4767573425815542
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.021564392	0.4745374174996246
BAND HETEROTOPIA; BH	0.021367433	0.47020321622869105
MELANOSIS, NEUROCUTANEOUS; NCMS	0.021367433	0.47020321622869105
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.021367433	0.47020321622869105
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.021367433	0.47020321622869105
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.021367433	0.47020321622869105
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.021367433	0.47020321622869105
KAGAMI-OGATA SYNDROME	0.021367433	0.47020321622869105
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.02136069	0.4700548324576021
RUVALCABA SYNDROME	0.02121359	0.46681780847314686
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.02121359	0.46681780847314686
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.02121359	0.46681780847314686
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.021155023	0.46552900640858125
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.021005811	0.46224550659370345
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.020925372	0.46047539801256415
GITELMAN SYNDROME	0.020915751	0.4602636821202837
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.020915751	0.4602636821202837
SCHEIE SYNDROME	0.0208333	0.4584492982688744
ATRIAL SEPTAL DEFECT 1	0.0208333	0.4584492982688744
MYCOSIS FUNGOIDES	0.0208333	0.4584492982688744
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.0208333	0.4584492982688744
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0208333	0.4584492982688744
CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL	0.0208333	0.4584492982688744
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.0208333	0.4584492982688744
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.0208333	0.4584492982688744
ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13	0.0208333	0.4584492982688744
STUVE-WIEDEMANN SYNDROME	0.020821390000000002	0.45818721155470127
IMMUNODEFICIENCY 53; IMD53	0.020820500000000002	0.45816762656934334
#613808 CILIARY DYSKINESIA, PRIMARY, 15; CILD15;;CILIARY DYSKINESIA, PRIMARY, 15, WITH OR WITHOUT SITUS INVERSUS	0.020820500000000002	0.45816762656934334
#615617 IMMUNODEFICIENCY 19; IMD19;;CD3-DELTA DEFICIENCY;;SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE,NK CELL-POSITIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.020820500000000002	0.45816762656934334
HYPERPROLINEMIA, TYPE I	0.020627533	0.453921271659701
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.020523551	0.4516330852018382
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.020523551	0.4516330852018382
ADAMS-OLIVER SYNDROME 5; AOS5	0.020523551	0.4516330852018382
HHHH SYNDROME	0.020523551	0.4516330852018382
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.020523551	0.4516330852018382
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.020523551	0.4516330852018382
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.020523551	0.4516330852018382
KNOBLOCH SYNDROME 1; KNO1	0.020523551	0.4516330852018382
METACHROMATIC LEUKODYSTROPHY	0.020523551	0.4516330852018382
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.020523551	0.4516330852018382
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.020523551	0.4516330852018382
ZTTK SYNDROME; ZTTKS	0.020517123	0.4514916331952299
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.020451682000000002	0.45005156462577556
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.020451682000000002	0.45005156462577556
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.020451682000000002	0.45005156462577556
ASPARTYLGLUCOSAMINURIA; AGU	0.020438641	0.4497645895762767
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.020311140999999998	0.4469588753817284
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.020285672	0.44639841471646613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.020278133	0.4462325144865626
#602398 DESMOSTEROLOSIS	0.020278133	0.4462325144865626
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.020239272	0.44537735480566576
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.020239272	0.44537735480566576
NOONAN SYNDROME 9; NS9	0.020239272	0.44537735480566576
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.020214623	0.4448349387336547
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.020214623	0.4448349387336547
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.02008149	0.4419052669857112
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.020025761	0.4406789168182761
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.02	0.4401120305173682
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02	0.4401120305173682
PREMATURE OVARIAN FAILURE 2B	0.02	0.4401120305173682
OVARIAN DYSGENESIS 7; ODG7	0.02	0.4401120305173682
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.02	0.4401120305173682
OVARIAN DYSGENESIS 2; ODG2	0.02	0.4401120305173682
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.02	0.4401120305173682
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.02	0.4401120305173682
ULNAR-MAMMARY SYNDROME; UMS	0.02	0.4401120305173682
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.019941432999999998	0.4388232284528026
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.019941432999999998	0.4388232284528026
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.019922423	0.43840490196779597
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.01973209	0.4342165098125728
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	0.4337696200567855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	0.4337696200567855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.019711782	0.4337696200567855
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.019711782	0.4337696200567855
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	0.4337696200567855
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.4337696200567855
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019711782	0.4337696200567855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	0.4337696200567855
Congenital disorder of glycosylation, type IIh	0.019711782	0.4337696200567855
PEHO-LIKE SYNDROME; PEHOL	0.019711782	0.4337696200567855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	0.4337696200567855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.019711782	0.4337696200567855
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.4337696200567855
FUMARASE DEFICIENCY; FMRD	0.019711782	0.4337696200567855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.019711782	0.4337696200567855
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	0.4337696200567855
BARAITSER-WINTER SYNDROME 2; BRWS2	0.019673241	0.432921502168377
OHDO SYNDROME	0.019673241	0.432921502168377
RAYNAUD DISEASE	0.0196078	0.4314814335989226
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.0196078	0.4314814335989226
VESICOURETERAL REFLUX 1	0.0196078	0.4314814335989226
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0196078	0.4314814335989226
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.4314814335989226
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.4314814335989226
PULMONARY HYPERTENSION, PRIMARY, 4	0.0196078	0.4314814335989226
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.0196078	0.4314814335989226
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0196078	0.4314814335989226
VAN DEN BOSCH SYNDROME	0.0196078	0.4314814335989226
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0196078	0.4314814335989226
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.4314814335989226
SPINAL ARACHNOIDITIS	0.0196078	0.4314814335989226
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.4314814335989226
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.0196078	0.4314814335989226
CARDIOMYOPATHY, DILATED, 2C; CMD2C	0.0196078	0.4314814335989226
KURU, SUSCEPTIBILITY TO	0.0196078	0.4314814335989226
#215300 CHONDROSARCOMA	0.0196078	0.4314814335989226
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0196078	0.4314814335989226
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.0196078	0.4314814335989226
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.4314814335989226
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.4314814335989226
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.4314814335989226
#614475 ATRIAL SEPTAL DEFECT 9; ASD9	0.0196078	0.4314814335989226
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0196078	0.4314814335989226
TOE, MISSHAPEN	0.0196078	0.4314814335989226
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.4314814335989226
#615342 PULMONARY HYPERTENSION, PRIMARY, 2; PPH2	0.0196078	0.4314814335989226
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.4314814335989226
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.4314814335989226
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.4314814335989226
CARPAL DISPLACEMENT	0.0196078	0.4314814335989226
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.4314814335989226
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.0196078	0.4314814335989226
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0196078	0.4314814335989226
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.4314814335989226
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.4314814335989226
MONOPHALANGY OF GREAT TOE	0.0196078	0.4314814335989226
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.4314814335989226
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.4314814335989226
OPTICOCOCHLEODENTATE DEGENERATION	0.0196078	0.4314814335989226
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.4314814335989226
KNUCKLE PADS	0.0196078	0.4314814335989226
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0196078	0.4314814335989226
#234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	0.0196078	0.4314814335989226
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.4314814335989226
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT	0.0196078	0.4314814335989226
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0196078	0.4314814335989226
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.4314814335989226
PUBIC BONE DYSPLASIA	0.0196078	0.4314814335989226
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0196078	0.4314814335989226
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.4314814335989226
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.0196078	0.4314814335989226
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.019545803	0.43011715232112335
SIFRIM-HITZ-WEISS SYNDROME	0.01939539	0.4268072237788129
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.01939539	0.4268072237788129
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.019362382	0.42608086288364705
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.019318309999999998	0.42511103201319894
LAZY LEUKOCYTE SYNDROME	0.019318309999999998	0.42511103201319894
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.019303533	0.4247858552394512
SEPTOOPTIC DYSPLASIA	0.019298872	0.42468328713073916
MICROPHTHALMIA, SYNDROMIC 1	0.019083841	0.41995140062903014
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.019018893	0.418522180821128
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.019016751	0.41847504482265957
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.018909723	0.416119829302549
NEPHRONOPHTHISIS 1	0.018907069999999998	0.41606144844170084
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0188679	0.41519948902993253
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.41519948902993253
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.41519948902993253
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.41519948902993253
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.41519948902993253
CARDIAC ARRHYTHMIA	0.0188679	0.41519948902993253
MYOPATHY, CONGENITAL	0.0188679	0.41519948902993253
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.41519948902993253
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.41519948902993253
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.41519948902993253
DIASTEMATOMYELIA	0.0188679	0.41519948902993253
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.41519948902993253
JUMPING FRENCHMAN OF MAINE	0.0188679	0.41519948902993253
TRANSSEXUALITY	0.0188679	0.41519948902993253
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.41519948902993253
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.41519948902993253
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.41519948902993253
ALCOHOL DEPENDENCE	0.0188679	0.41519948902993253
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.41519948902993253
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	0.41519948902993253
PALMOMENTAL REFLEX	0.0188679	0.41519948902993253
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.41519948902993253
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.41519948902993253
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.41519948902993253
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.41519948902993253
ERYTHERMALGIA, PRIMARY	0.0188679	0.41519948902993253
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.41519948902993253
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.41519948902993253
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	0.41519948902993253
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	0.41519948902993253
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.41519948902993253
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0188679	0.41519948902993253
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.41519948902993253
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.41519948902993253
269800 SENILE PLAQUE FORMATION	0.0188679	0.41519948902993253
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.41519948902993253
MOTION SICKNESS	0.0188679	0.41519948902993253
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.41519948902993253
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.41519948902993253
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.41519948902993253
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.41519948902993253
CERVICAL RIB	0.0188679	0.41519948902993253
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0188679	0.41519948902993253
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.41519948902993253
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.41519948902993253
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.41519948902993253
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.018825692999999998	0.41427069860633015
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.01875749	0.41276985056546145
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01875749	0.41276985056546145
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.01875749	0.41276985056546145
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.01875749	0.41276985056546145
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.01875749	0.41276985056546145
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.018598223	0.40926508442724097
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.0185185	0.40751073185679415
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.0185185	0.40751073185679415
FIBROCHONDROGENESIS 1; FBCG1	0.0185185	0.40751073185679415
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	0.0185185	0.40751073185679415
CRANIOECTODERMAL DYSPLASIA 1	0.0185185	0.40751073185679415
ATELOSTEOGENESIS, TYPE I; AO1	0.0185185	0.40751073185679415
RHIZOMELIC SYNDROME	0.0185185	0.40751073185679415
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.0185185	0.40751073185679415
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	0.0185185	0.40751073185679415
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.0185185	0.40751073185679415
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0185185	0.40751073185679415
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0185185	0.40751073185679415
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0185185	0.40751073185679415
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.0185185	0.40751073185679415
#602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPEMETAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED	0.0185185	0.40751073185679415
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.0185185	0.40751073185679415
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.0185185	0.40751073185679415
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.0185185	0.40751073185679415
CLEIDORHIZOMELIC SYNDROME	0.0185185	0.40751073185679415
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3	0.0185185	0.40751073185679415
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0185185	0.40751073185679415
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.0185185	0.40751073185679415
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.018459651	0.4062157242125984
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.018459651	0.4062157242125984
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.01845499	0.40611315610388626
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.01845499	0.40611315610388626
#612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B;;IGHD IB;;DWARFISM OF SINDH	0.01845499	0.40611315610388626
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.018387782000000002	0.40463420363653574
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.018387782000000002	0.40463420363653574
#615214 AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO PIK3R1 DEFECT	0.0183093	0.40290716001758253
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.018181799999999998	0.40010144582303425
CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	0.018181799999999998	0.40010144582303425
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.018181799999999998	0.40010144582303425
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.018181799999999998	0.40010144582303425
#611363 ATRIAL SEPTAL DEFECT 4; ASD4	0.018181799999999998	0.40010144582303425
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.018181799999999998	0.40010144582303425
#613426 CARDIOMYOPATHY, DILATED, 1S; CMD1SLEFT VENTRICULAR NONCOMPACTION 5, INCLUDED; LVNC5, INCLUDED	0.018181799999999998	0.40010144582303425
COARCTATION OF AORTA	0.018181799999999998	0.40010144582303425
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.018181799999999998	0.40010144582303425
HEMIFACIAL MICROSOMIA	0.018181799999999998	0.40010144582303425
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.018181799999999998	0.40010144582303425
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.018181799999999998	0.40010144582303425
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.018181799999999998	0.40010144582303425
HYPOTONIA-CYSTINURIA SYNDROME	0.018085282	0.3979775091749605
TEMPLE SYNDROME	0.017850880000000003	0.3928193521660939
AICARDI-GOUTIERES SYNDROME 6	0.017793082	0.39154747240910176
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.01778617	0.39139536969135497
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.0175439	0.38606407260968284
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.0175439	0.38606407260968284
15q26 overgrowth syndrome	0.0175439	0.38606407260968284
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0175439	0.38606407260968284
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0175439	0.38606407260968284
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0175439	0.38606407260968284
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0175439	0.38606407260968284
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.0175439	0.38606407260968284
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.0175439	0.38606407260968284
#613988 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3; DKCB3	0.0175439	0.38606407260968284
AUROCEPHALOSYNDACTYLY	0.0175439	0.38606407260968284
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.0175439	0.38606407260968284
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0175439	0.38606407260968284
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0175439	0.38606407260968284
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0175439	0.38606407260968284
184705 STEINFELD SYNDROME	0.0175439	0.38606407260968284
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0175439	0.38606407260968284
TRISOMY 18-LIKE SYNDROME	0.0175439	0.38606407260968284
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.0175439	0.38606407260968284
JACOBSEN SYNDROME	0.01749861	0.38506743891657624
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0172414	0.37940737814810765
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0172414	0.37940737814810765
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0172414	0.37940737814810765
PREECLAMPSIA/ECLAMPSIA 1	0.017217081	0.37887222392459996
RECOMBINANT CHROMOSOME 8 SYNDROME	0.017208223	0.3786772983062839
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.01715009	0.37739804667278054
Mulchandani-Bhoj-Conlin syndrome	0.01715009	0.37739804667278054
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.01715009	0.37739804667278054
IMMUNODEFICIENCY 47	0.017044750999999997	0.37507999861364705
PORPHYRIA, ACUTE HEPATIC	0.0169492	0.3729773413822489
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.0169492	0.3729773413822489
GLYCOGEN STORAGE DISEASE VII	0.0169492	0.3729773413822489
ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO	0.0169492	0.3729773413822489
URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIADUE TO	0.0169492	0.3729773413822489
ELLIPTOCYTOSIS 1; EL1	0.0169492	0.3729773413822489
SPECTRIN, BETA, ERYTHROCYTIC	0.0169492	0.3729773413822489
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.0169492	0.3729773413822489
PYROPOIKILOCYTOSIS, HEREDITARY	0.0169492	0.3729773413822489
GLUTATHIONE REDUCTASE	0.0169492	0.3729773413822489
#612631 ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO	0.0169492	0.3729773413822489
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0169492	0.3729773413822489
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.0169492	0.3729773413822489
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.0169492	0.3729773413822489
SPHEROCYTOSIS, AUTOSOMAL RECESSIVE	0.0169492	0.3729773413822489
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.0169492	0.3729773413822489
OVALOCYTOSIS, HEREDITARY HEMOLYTIC	0.0169492	0.3729773413822489
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0169492	0.3729773413822489
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.0169492	0.3729773413822489
ELLIPTOCYTOSIS 2; EL2	0.0169492	0.3729773413822489
GALACTOSEMIA	0.0169492	0.3729773413822489
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.0169492	0.3729773413822489
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.0169492	0.3729773413822489
SPHEROCYTOSIS, TYPE 1; SPH1	0.0169492	0.3729773413822489
GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIADUE TO	0.0169492	0.3729773413822489
6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY	0.0169492	0.3729773413822489
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.0169492	0.3729773413822489
SPHEROCYTOSIS, TYPE 2	0.0169492	0.3729773413822489
RH-NULL, REGULATOR TYPE; RHNR	0.0169492	0.3729773413822489
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.0169492	0.3729773413822489
AL KAISSI SYNDROME; ALKAS	0.016891013000000003	0.3716969014462632
MICROHYDRANENCEPHALY; MHAC	0.01683859	0.3705433017974726
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.016685033	0.36716418764396475
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.016572641	0.3646909340772694
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	0.3639891754446094
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.016468882	0.3624076548685468
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	0.3624076548685468
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.3624076548685468
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	0.3624076548685468
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.016468882	0.3624076548685468
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016468882	0.3624076548685468
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	0.3624076548685468
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.016468882	0.3624076548685468
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	0.3624076548685468
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.016450463	0.3620023336940418
PRECOCIOUS PUBERTY, CENTRAL	0.01613899	0.35514818296997497
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01613899	0.35514818296997497
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.01613899	0.35514818296997497
#613912 COMPLEMENT FACTOR D DEFICIENCY; CFDD;;FACTOR D DEFICIENCY	0.016128999999999998	0.35492834701073156
SPECIFIC GRANULE DEFICIENCY	0.016128999999999998	0.35492834701073156
IMMUNODEFICIENCY 33	0.016128999999999998	0.35492834701073156
COMPLEMENT FACTOR H DEFICIENCY	0.016128999999999998	0.35492834701073156
NEUTROPHIL ACTIN DYSFUNCTION	0.016128999999999998	0.35492834701073156
ACERULOPLASMINEMIA	0.01601602	0.35244215415033897
DESBUQUOIS DYSPLASIA 2; DBQD2	0.015975262	0.3515452498433476
COFFIN-SIRIS SYNDROME 5	0.015799023	0.34766700463603006
LUSCAN-LUMISH SYNDROME; LLS	0.015793723000000003	0.34755037494794305
TOWNES-BROCKS SYNDROME 1; TBS1	0.015769282	0.34701253604104926
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.015677423000000003	0.3449911234904846
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.015677423000000003	0.3449911234904846
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.015677423000000003	0.3449911234904846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.015625	0.3438375238416939
PAINE SYNDROME	0.015625	0.3438375238416939
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.3438375238416939
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.3438375238416939
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	0.3438375238416939
CARNOSINEMIA	0.015625	0.3438375238416939
HYDROXYLYSINURIA	0.015625	0.3438375238416939
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	0.3438375238416939
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.3438375238416939
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.3438375238416939
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.3437638270821837
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.3437638270821837
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015549782	0.34218230650612114
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	0.34218230650612114
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	0.34218230650612114
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	0.34218230650612114
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.015549782	0.34218230650612114
3MC SYNDROME 1	0.015448590000000002	0.3399555156765155
JOUBERT SYNDROME 10	0.015200482	0.3344957498931353
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.015010383	0.33031250704866927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.014925399999999998	0.3284424050141963
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.014925399999999998	0.3284424050141963
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.014925399999999998	0.3284424050141963
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.014925399999999998	0.3284424050141963
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.014925399999999998	0.3284424050141963
#612885 PREMATURE OVARIAN FAILURE 10; POF10MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3, INCLUDED;MENOQ3, INCLUDED	0.014925399999999998	0.3284424050141963
ALLAN-HERNDON-DUDLEY SYNDROME	0.014925399999999998	0.3284424050141963
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.014883272	0.3275153530331146
COFFIN-SIRIS SYNDROME 7; CSS7	0.014877972000000003	0.32739872334502756
LARSEN-LIKE SYNDROME	0.014877972000000003	0.32739872334502756
FILIPPI SYNDROME; FLPIS	0.014833541	0.32642099246363165
MARDEN-WALKER SYNDROME	0.014833541	0.32642099246363165
BRANCHIOOCULOFACIAL SYNDROME	0.014833541	0.32642099246363165
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.014761672000000002	0.324839471887569
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.014761672	0.324839471887569
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.014761672	0.324839471887569
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.014761672	0.324839471887569
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.32361217547926824
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.32361217547926824
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0147059	0.32361217547926824
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.32361217547926824
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.32361217547926824
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.32361217547926824
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.32361217547926824
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.32361217547926824
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.014690829999999998	0.3232805510642734
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.014580133000000002	0.32084459699216444
Muenke syndrome	0.014580133000000002	0.32084459699216444
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.014580133000000002	0.32084459699216444
SECKEL SYNDROME 4	0.014464340000000001	0.3182965023746795
ALAZAMI SYNDROME; ALAZS	0.014177182	0.3119774178517142
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.014166501	0.3117423760218163
Trichothiodystrophy 5, nonphotosensitive	0.01403939	0.30894522200626173
MUCOPOLYSACCHARIDOSIS TYPE IX	0.014034090000000003	0.30882859231817467
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.014034090000000003	0.30882859231817467
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.013917790000000001	0.3062693408607161
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.013736251000000001	0.3022744659653115
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.013669681999999999	0.30080957507733597
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01365217	0.30042421298341493
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.013576423	0.298757354684635
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.013559479999999999	0.29838451377798214
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.01334759	0.29372174687066593
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	0.01334759	0.29372174687066593
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0133333	0.2934072868248613
METATROPIC DYSPLASIA	0.0133333	0.2934072868248613
MORQUIO SYNDROME C	0.0133333	0.2934072868248613
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.0133333	0.2934072868248613
GERODERMA OSTEODYSPLASTICUM; GO	0.0133333	0.2934072868248613
SYNDESMODYSPLASIC DWARFISM	0.0133333	0.2934072868248613
DWARFISM, PROPORTIONATE, WITH HIP DISLOCATION	0.0133333	0.2934072868248613
TRYPTOPHANURIA WITH DWARFISM	0.0133333	0.2934072868248613
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.0133333	0.2934072868248613
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.0133333	0.2934072868248613
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.0133333	0.2934072868248613
#168400 PARASTREMMATIC DWARFISM	0.0133333	0.2934072868248613
BOOMERANG DYSPLASIA	0.0133333	0.2934072868248613
DWARFISM WITH TALL VERTEBRAE	0.0133333	0.2934072868248613
SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM	0.0133333	0.2934072868248613
CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS	0.0133333	0.2934072868248613
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0133333	0.2934072868248613
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.0133333	0.2934072868248613
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.0133333	0.2934072868248613
DWARFISM, LEVI TYPE	0.0133333	0.2934072868248613
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0133333	0.2934072868248613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0133333	0.2934072868248613
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.0133333	0.2934072868248613
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.0133333	0.2934072868248613
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.0133333	0.2934072868248613
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.0133333	0.2934072868248613
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.0133333	0.2934072868248613
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.0133333	0.2934072868248613
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.0133333	0.2934072868248613
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0133333	0.2934072868248613
ACROMICRIC DYSPLASIA	0.0133333	0.2934072868248613
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0133333	0.2934072868248613
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013074223000000001	0.2877061415983439
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.013074223000000001	0.2877061415983439
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.013074223000000001	0.2877061415983439
CHROMOSOME 10Q26 DELETION SYNDROME	0.013074223000000001	0.2877061415983439
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.013074223000000001	0.2877061415983439
JOUBERT SYNDROME 14	0.012994192	0.2859450113026271
NEPHRONOPHTHISIS 11; NPHP11	0.012948232	0.2849336338564982
AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT	0.012820500000000002	0.282122814362396
OTITIS MEDIA, SUSCEPTIBILITY TO; OMS	0.012820500000000002	0.282122814362396
CILIARY DYSKINESIA, PRIMARY, 21; CILD21	0.012820500000000002	0.282122814362396
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.012820500000000002	0.282122814362396
TURNPENNY-FRY SYNDROME; TPFS	0.012660672000000001	0.2786057030817195
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.01243858	0.27371843502763626
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.01243858	0.27371843502763626
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.01243858	0.27371843502763626
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.01243858	0.27371843502763626
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.012407183	0.2730275251565286
CORNELIA DE LANGE SYNDROME 3	0.012407183	0.2730275251565286
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.012407183	0.2730275251565286
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.012379143	0.2724104880897432
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.012230341	0.269136010571491
MICROPHTHALMIA, SYNDROMIC 3	0.012158472000000002	0.2675544899954284
NEPHRONOPHTHISIS 4	0.01210435	0.26636350282964527
DIAMOND-BLACKFAN ANEMIA 9	0.01210435	0.26636350282964527
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.01210435	0.26636350282964527
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.011982233	0.2636762447881108
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.011860633	0.26100036364256524
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.011860633	0.26100036364256524
NOONAN SYNDROME 7; NS7	0.011563301	0.2544573941296757
#613707 LEOPARD SYNDROME 3; LPRD3	0.011563301	0.2544573941296757
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.011563301	0.2544573941296757
#300555 DENT DISEASE 2	0.011491432000000001	0.2528758735536131
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.011491432000000001	0.2528758735536131
DYSTONIA 28, CHILDHOOD-ONSET	0.011491432000000001	0.2528758735536131
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.011417432	0.25124745904069884
COLE-CARPENTER SYNDROME 2; CLCRP2	0.011314590000000001	0.2489843589685755
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.011314590000000001	0.2489843589685755
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.011314590000000001	0.2489843589685755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.011258243	0.24774440933939731
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.011225050999999998	0.24701399941355068
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.011193593	0.24632174720074998
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.011193593	0.24632174720074998
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.011193593	0.24632174720074998
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.011193593	0.24632174720074998
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.011193593	0.24632174720074998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.011193593	0.24632174720074998
SENGERS SYNDROME	0.01102941	0.2427088015254283
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.011018893	0.24247736861418073
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.011018893	0.24247736861418073
GM2-GANGLIOSIDOSIS, AB VARIANT	0.011018893	0.24247736861418073
WAISMAN SYNDROME; WSMN	0.011018893	0.24247736861418073
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.011018893	0.24247736861418073
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.011016751	0.2424302326157123
LISSENCEPHALY, X-LINKED, 1; LISX1	0.011016751	0.2424302326157123
WARBURG MICRO SYNDROME 3; WARBM3	0.011016751	0.2424302326157123
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.010973223	0.24147237279249437
3MC SYNDROME 2	0.010944882000000001	0.24084871203964975
CHROMOSOME 4q21 DELETION SYNDROME	0.010944882000000001	0.24084871203964975
CHROMOSOME 16Q22 DELETION SYNDROME	0.010944882000000001	0.24084871203964975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.010768643	0.2369704668323322
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.010768643	0.2369704668323322
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.010768643	0.2369704668323322
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01064755	0.2343057425267602
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.01064755	0.2343057425267602
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.01064755	0.2343057425267602
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.01064755	0.2343057425267602
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.01064755	0.2343057425267602
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.01037797	0.2283734724674166
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.010349711	0.22775161617389705
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.010349711	0.22775161617389705
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.010349711	0.22775161617389705
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.010309299999999999	0.2268623478106352
NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA	0.010309299999999999	0.2268623478106352
FELTY SYNDROME	0.010309299999999999	0.2268623478106352
#607847 NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS;;NONIMMUNE CHRONIC IDIOPATHIC NEUTROPENIA OF ADULTS;;NI-CINA	0.010309299999999999	0.2268623478106352
DIAMOND-BLACKFAN ANEMIA 18; DBA18	0.010309299999999999	0.2268623478106352
#613107 NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2	0.010309299999999999	0.2268623478106352
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.010277842	0.22617009559783444
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.010277842	0.22617009559783444
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.010277842	0.22617009559783444
BARDET-BIEDL SYNDROME 17; BBS17	0.010277842	0.22617009559783444
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.010277842	0.22617009559783444
SPINOCEREBELLAR ATAXIA 5; SCA5	0.010277842	0.22617009559783444
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.010277842	0.22617009559783444
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.010277842	0.22617009559783444
BARDET-BIEDL SYNDROME 8; BBS8	0.010277842	0.22617009559783444
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010277842	0.22617009559783444
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.010277842	0.22617009559783444
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.010277842	0.22617009559783444
JOUBERT SYNDROME 31; JBTS31	0.010277842	0.22617009559783444
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010277842	0.22617009559783444
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.010277842	0.22617009559783444
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.010277842	0.22617009559783444
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.010277842	0.22617009559783444
VELOCARDIOFACIAL SYNDROME	0.0102226	0.22495446215834242
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0102226	0.22495446215834242
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.010175011	0.22390723758732786
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.010175011	0.22390723758732786
CHOREOATHETOSIS, FAMILIAL INVERTED	0.010175011	0.22390723758732786
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.010175011	0.22390723758732786
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.010175011	0.22390723758732786
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.010175011	0.22390723758732786
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.010175011	0.22390723758732786
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.010175011	0.22390723758732786
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.010175011	0.22390723758732786
KUFOR-RAKEB SYNDROME	0.010175011	0.22390723758732786
FLYNN-AIRD SYNDROME	0.010175011	0.22390723758732786
HUNTINGTON DISEASE; HD	0.010175011	0.22390723758732786
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.010175011	0.22390723758732786
HYDROCEPHALUS, NORMAL-PRESSURE	0.010103142	0.22232571701126524
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.010103142	0.22232571701126524
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.010103142	0.22232571701126524
#615361 HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2	0.010101	0.22227858101279682
GLYCOGEN STORAGE DISEASE VI	0.010101	0.22227858101279682
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.010101	0.22227858101279682
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.010101	0.22227858101279682
WARBURG MICRO SYNDROME 2; WARBM2	0.010101	0.22227858101279682
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.010101	0.22227858101279682
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.010101	0.22227858101279682
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.010057472000000001	0.22132072118957882
IMMUNODEFICIENCY 37; IMD37	0.009924760999999999	0.21840033580547927
224250 DYSMYELINATION WITH JAUNDICE	0.009924760999999999	0.21840033580547927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.009924760999999999	0.21840033580547927
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.009924760999999999	0.21840033580547927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.009924760999999999	0.21840033580547927
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.009924760999999999	0.21840033580547927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.009852892	0.21681881522941665
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.009852892	0.21681881522941665
MACROCEPHALY/AUTISM SYNDROME	0.009852892	0.21681881522941665
NETHERTON SYNDROME; NETH	0.009852892	0.21681881522941665
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.009852892	0.21681881522941665
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.009852892	0.21681881522941665
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.009759633	0.2147665948367157
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.009759633	0.2147665948367157
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.009759633	0.2147665948367157
Xq28 (MECP2) duplication	0.009759633	0.2147665948367157
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.009729983	0.21411412875147368
BARDET-BIEDL SYNDROME 5; BBS5	0.00943396	0.20759996457098154
JOUBERT SYNDROME 4	0.00943396	0.20759996457098154
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00943396	0.20759996457098154
SPINOCEREBELLAR ATAXIA 42	0.00943396	0.20759996457098154
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00943396	0.20759996457098154
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00943396	0.20759996457098154
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00943396	0.20759996457098154
SPINOCEREBELLAR ATAXIA 1	0.00943396	0.20759996457098154
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00943396	0.20759996457098154
SCHIZOPHRENIA 19; SCZD19	0.00943396	0.20759996457098154
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00943396	0.20759996457098154
DYSTONIA 16; DYT16	0.00943396	0.20759996457098154
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00943396	0.20759996457098154
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00943396	0.20759996457098154
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00943396	0.20759996457098154
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00943396	0.20759996457098154
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00943396	0.20759996457098154
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00943396	0.20759996457098154
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00943396	0.20759996457098154
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00943396	0.20759996457098154
COWCHOCK SYNDROME; COWCK	0.00943396	0.20759996457098154
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00943396	0.20759996457098154
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.00943396	0.20759996457098154
BARDET-BIEDL SYNDROME 10; BBS10	0.00943396	0.20759996457098154
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00943396	0.20759996457098154
BARDET-BIEDL SYNDROME 18; BBS18	0.00943396	0.20759996457098154
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00943396	0.20759996457098154
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00943396	0.20759996457098154
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.00943396	0.20759996457098154
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00943396	0.20759996457098154
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00943396	0.20759996457098154
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00943396	0.20759996457098154
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00943396	0.20759996457098154
DEMENTIA, FAMILIAL DANISH	0.00925926	0.20375558598441235
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00925926	0.20375558598441235
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00925926	0.20375558598441235
DEMENTIA, LEWY BODY; DLB	0.00925926	0.20375558598441235
ALZHEIMER DISEASE 2	0.00925926	0.20375558598441235
MAST SYNDROME	0.00925926	0.20375558598441235
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.00925926	0.20375558598441235
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.00925926	0.20375558598441235
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.00925926	0.20375558598441235
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00925926	0.20375558598441235
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00925926	0.20375558598441235
POPLITEAL PTERYGIUM SYNDROME	0.00925926	0.20375558598441235
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00925926	0.20375558598441235
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00925926	0.20375558598441235
PARKINSON DISEASE, LATE-ONSET; PD	0.00925926	0.20375558598441235
SPINOCEREBELLAR ATAXIA 12	0.00925926	0.20375558598441235
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.00925926	0.20375558598441235
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00925926	0.20375558598441235
PRESENILE DEMENTIA, KRAEPELIN TYPE	0.00925926	0.20375558598441235
ALZHEIMER DISEASE	0.00925926	0.20375558598441235
Early-onset Alzheimer disease with cerebral amyloid angiopathy	0.00925926	0.20375558598441235
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.00925926	0.20375558598441235
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00925926	0.20375558598441235
AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA	0.00925926	0.20375558598441235
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00925926	0.20375558598441235
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.00925926	0.20375558598441235
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.00925926	0.20375558598441235
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00925926	0.20375558598441235
LEBER OPTIC ATROPHY AND DYSTONIA	0.00925926	0.20375558598441235
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.00925926	0.20375558598441235
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.00925926	0.20375558598441235
HUNTINGTON DISEASE-LIKE 1	0.00925926	0.20375558598441235
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.00925926	0.20375558598441235
MACHADO-JOSEPH DISEASE; MJD	0.00925926	0.20375558598441235
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00925926	0.20375558598441235
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00925926	0.20375558598441235
HUNTINGTON DISEASE-LIKE 2	0.00925926	0.20375558598441235
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00925926	0.20375558598441235
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL	0.00925926	0.20375558598441235
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00921359	0.20275059016272595
MARTSOLF SYNDROME	0.00921359	0.20275059016272595
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00921359	0.20275059016272595
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.00921359	0.20275059016272595
CHITAYAT SYNDROME	0.00921359	0.20275059016272595
NIEMANN-PICK DISEASE, TYPE B	0.00921359	0.20275059016272595
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00900901	0.19824868420256375
#300291 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY;;HED-IDECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNE DEFICIENCY, INCLUDED;;EDA-ID, INCLUDED;;HYPER-IGM IMMUNODEFICIENCY, X-LINKED, WITH HYPOHIDROTIC ECTODERMALDYSPLASIA, INCLUDED;;XHM-ED, INCLUDED	0.00900901	0.19824868420256375
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00900901	0.19824868420256375
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00900901	0.19824868420256375
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00900901	0.19824868420256375
IMMUNODEFICIENCY 9; IMD9	0.00900901	0.19824868420256375
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00900901	0.19824868420256375
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00900901	0.19824868420256375
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.00900901	0.19824868420256375
CYSTIC DISEASE OF LUNG	0.00900901	0.19824868420256375
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00900901	0.19824868420256375
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00900901	0.19824868420256375
#609536 COMPLEMENT COMPONENT 5 DEFICIENCY; C5D;;C5 DEFICIENCY	0.00900901	0.19824868420256375
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00900901	0.19824868420256375
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00900901	0.19824868420256375
#300301 ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS,AND LYMPHEDEMA; OLEDAID	0.00900901	0.19824868420256375
#614102 IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD;;KAPPA CHAIN DEFICIENCY	0.00900901	0.19824868420256375
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00900901	0.19824868420256375
NEUROFIBROMATOSIS, TYPE I	0.008932061	0.19655537517074972
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.008915751	0.19619646380986278
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008843882	0.19461494323380019
#615401 IMMUNODEFICIENCY 8; IMD8	0.008843882	0.19461494323380019
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.008814232	0.19396247714855816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.008655043	0.1904594274472567
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.008516393	0.18740835079569507
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.008516393	0.18740835079569507
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008516392999999999	0.18740835079569504
HUNTER-MACDONALD SYNDROME	0.00801631	0.1764037235678342
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00801631	0.1764037235678342
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.008	0.1760448122069473
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.008	0.1760448122069473
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.008	0.1760448122069473
#613807 CILIARY DYSKINESIA, PRIMARY, 14; CILD14;;CILIARY DYSKINESIA, PRIMARY, 14, WITH OR WITHOUT SITUS INVERSUS	0.008	0.1760448122069473
IMMUNODEFICIENCY 43	0.008	0.1760448122069473
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.008	0.1760448122069473
#610913 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2;;INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN C DEFICIENCY;;DESQUAMATIVE INTERSTITIAL PNEUMONITIS DUE TO SURFACTANT PROTEIN CDEFICIENCY;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 2	0.008	0.1760448122069473
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.008	0.1760448122069473
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.008	0.1760448122069473
#614699 IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7	0.008	0.1760448122069473
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.008	0.1760448122069473
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.008	0.1760448122069473
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.008	0.1760448122069473
RETINITIS PIGMENTOSA 6	0.008	0.1760448122069473
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.008	0.1760448122069473
#608644 CILIARY DYSKINESIA, PRIMARY, 3; CILD3;;CILIARY DYSKINESIA, PRIMARY, 3, WITH OR WITHOUT SITUS INVERSUS	0.008	0.1760448122069473
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.008	0.1760448122069473
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.008	0.1760448122069473
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.008	0.1760448122069473
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.008	0.1760448122069473
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.008	0.1760448122069473
SPINAL MUSCULAR ATROPHY, TYPE II	0.008	0.1760448122069473
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.008	0.1760448122069473
THORACIC DYSOSTOSIS, ISOLATED	0.008	0.1760448122069473
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00797035	0.17539234612170526
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.00797035	0.17539234612170526
FORSYTHE-WAKELING SYNDROME; FWS	0.007739292	0.1703077758443412
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.16984959721497106
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.007718471	0.16984959721497106
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.007672511	0.16883821976884217
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0076006419999999995	0.16725669919277952
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.007441453	0.16375364949147805
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.007441453	0.16375364949147805
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.007441453	0.16375364949147805
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.007107223	0.15639871729348706
KLEEFSTRA SYNDROME 2; KLEFS2	0.007107223	0.15639871729348706
SALLA DISEASE	0.007107223	0.15639871729348706
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007107223	0.15639871729348706
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.007107223	0.15639871729348706
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.007107223	0.15639871729348706
ADENYLOSUCCINASE DEFICIENCY	0.007107223	0.15639871729348706
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.007107223	0.15639871729348706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.007107223	0.15639871729348706
CHROMOSOME 5Q12 DELETION SYNDROME	0.007107223	0.15639871729348706
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.007107223	0.15639871729348706
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.007107223	0.15639871729348706
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.007107223	0.15639871729348706
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.007107223	0.15639871729348706
HEART AND BRAIN MALFORMATION SYNDROME	0.007107223	0.15639871729348706
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.007107223	0.15639871729348706
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.007107223	0.15639871729348706
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.007107223	0.15639871729348706
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.007107223	0.15639871729348706
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.007107223	0.15639871729348706
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.14969794561205554
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.14969794561205554
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.14969794561205554
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.14969794561205554
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.14969794561205554
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.14969794561205554
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00680272	0.14969794561205554
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.14969794561205554
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.14969794561205554
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.14969794561205554
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.14969794561205554
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.14969794561205554
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00680272	0.14969794561205554
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.14969794561205554
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.14969794561205554
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00680272	0.14969794561205554
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00680272	0.14969794561205554
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.00680272	0.14969794561205554
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.14969794561205554
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.00680272	0.14969794561205554
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.14969794561205554
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.14969794561205554
Paragangliomas 6	0.00680272	0.14969794561205554
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.14969794561205554
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00680272	0.14969794561205554
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.14969794561205554
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.14969794561205554
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00680272	0.14969794561205554
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.14969794561205554
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00680272	0.14969794561205554
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00680272	0.14969794561205554
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.14969794561205554
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.14969794561205554
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.14969794561205554
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.14969794561205554
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.00680272	0.14969794561205554
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.14969794561205554
LONG QT SYNDROME 13; LQT13	0.00680272	0.14969794561205554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.006790013000000001	0.14941832043346637
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.006790013000000001	0.14941832043346637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.006790013000000001	0.14941832043346637
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.006790013000000001	0.14941832043346637
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.006790013000000001	0.14941832043346637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.006790013000000001	0.14941832043346637
CHROMOSOME 1p35 DELETION SYNDROME	0.006790013000000001	0.14941832043346637
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00675676	0.14868656816592662
#174900 JUVENILE POLYPOSIS SYNDROME; JPS;;POLYPOSIS, JUVENILE INTESTINAL; PJI;;JUVENILE INTESTINAL POLYPOSIS; JIP;;POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACTJUVENILE POLYPOSIS OF STOMACH, INCLUDED;;JUVENILE POLYPOSIS COLI, INCLUDED	0.00675676	0.14868656816592662
LYMPHATIC MALFORMATION 7; LMPHM7	0.00675676	0.14868656816592662
DIAMOND-BLACKFAN ANEMIA 16	0.00675676	0.14868656816592662
#611283 ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;;IBD DEFICIENCY;;ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8, DEFICIENCY OF;;ACAD8 DEFICIENCY	0.00675676	0.14868656816592662
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00675676	0.14868656816592662
SENIOR-LOKEN SYNDROME 4; SLSN4	0.00675676	0.14868656816592662
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.00675676	0.14868656816592662
#613977 CYANOSIS, TRANSIENT NEONATAL; TNCY	0.00675676	0.14868656816592662
DIAMOND-BLACKFAN ANEMIA 17	0.00675676	0.14868656816592662
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00675676	0.14868656816592662
HYDROPS FETALIS, NONIMMUNE	0.00675676	0.14868656816592662
HEMOGLOBIN--DELTA LOCUS	0.00675676	0.14868656816592662
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00675676	0.14868656816592662
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00675676	0.14868656816592662
HEMOCHROMATOSIS, TYPE 2B	0.00675676	0.14868656816592662
DIAMOND-BLACKFAN ANEMIA-LIKE; DBAL	0.00675676	0.14868656816592662
DOHLE BODIES AND LEUKEMIA	0.00675676	0.14868656816592662
SENIOR-LOKEN SYNDROME 1	0.00675676	0.14868656816592662
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00675676	0.14868656816592662
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.006597571	0.14518351846462518
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00656118	0.14438271261949728
3MC SYNDROME 3	0.00656118	0.14438271261949728
SECKEL SYNDROME 2; SCKL2	0.00656118	0.14438271261949728
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00656118	0.14438271261949728
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0065257019999999995	0.14360199788856254
AICARDI-GOUTIERES SYNDROME 5	0.0065257019999999995	0.14360199788856254
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.006263341	0.1378285862666342
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.006263341	0.1378285862666342
GAPO SYNDROME; GAPOS	0.006263341	0.1378285862666342
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.006263341	0.1378285862666342
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.006263341	0.1378285862666342
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.006263341	0.1378285862666342
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.006263341	0.1378285862666342
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.006263341	0.1378285862666342
THREONINEMIA	0.006263341	0.1378285862666342
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.006191472	0.13624706569057154
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.006191472	0.13624706569057154
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.006191472	0.13624706569057154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.006191472	0.13624706569057154
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.006191472	0.13624706569057154
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.006191472	0.13624706569057154
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.006191472	0.13624706569057154
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.006191472	0.13624706569057154
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.006191472	0.13624706569057154
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.006191472	0.13624706569057154
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.005946131	0.13084818940661347
MENKES DISEASE	0.005946131	0.13084818940661347
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005946131	0.13084818940661347
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.005946131	0.13084818940661347
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005946131	0.13084818940661347
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.005946131	0.13084818940661347
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.005946131	0.13084818940661347
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.005874262	0.12926666883055082
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.005874262	0.12926666883055082
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.005874262	0.12926666883055082
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.005874262	0.12926666883055082
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005874262	0.12926666883055082
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.005874262	0.12926666883055082
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.005874262	0.12926666883055082
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005874262	0.12926666883055082
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.005874262	0.12926666883055082
TYSHCHENKO SYNDROME	0.005874262	0.12926666883055082
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.005874262	0.12926666883055082
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.12503186686170964
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.12503186686170964
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.12503186686170964
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.12503186686170964
PLATELET DISORDER, UNDEFINED	0.00568182	0.12503186686170964
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.12503186686170964
THROMBOCYTOPENIA 2	0.00568182	0.12503186686170964
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.12503186686170964
SEBASTIAN SYNDROME	0.00568182	0.12503186686170964
Bernard-Soulier syndrome	0.00568182	0.12503186686170964
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00568182	0.12503186686170964
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.12503186686170964
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.12503186686170964
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.12503186686170964
MONOSOMY 7 OF BONE MARROW	0.00568182	0.12503186686170964
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.12503186686170964
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.00568182	0.12503186686170964
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.12503186686170964
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.12503186686170964
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.12503186686170964
THROMBOCYTOPENIA 6	0.00568182	0.12503186686170964
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.12503186686170964
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.12503186686170964
MACDERMOT-WINTER SYNDROME	0.0055764230000000005	0.1227125424776877
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0055764230000000005	0.1227125424776877
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0055764230000000005	0.1227125424776877
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0055764230000000005	0.1227125424776877
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0055764230000000005	0.1227125424776877
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.0055764230000000005	0.1227125424776877
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0055764230000000005	0.1227125424776877
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0055764230000000005	0.1227125424776877
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0055764230000000005	0.1227125424776877
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.0055764230000000005	0.1227125424776877
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0055764230000000005	0.1227125424776877
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0055764230000000005	0.1227125424776877
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0055764230000000005	0.1227125424776877
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00534759	0.11767693466371866
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00534759	0.11767693466371866
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00534759	0.11767693466371866
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.00534759	0.11767693466371866
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00534759	0.11767693466371866
GLYCOGEN STORAGE DISEASE IXC	0.00534759	0.11767693466371866
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00534759	0.11767693466371866
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00534759	0.11767693466371866
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.00534759	0.11767693466371866
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00534759	0.11767693466371866
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00534759	0.11767693466371866
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.00534759	0.11767693466371866
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00534759	0.11767693466371866
COLOBOMA, OCULAR	0.00534759	0.11767693466371866
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00534759	0.11767693466371866
CHYLOMICRON RETENTION DISEASE	0.00534759	0.11767693466371866
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00534759	0.11767693466371866
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.00534759	0.11767693466371866
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00534759	0.11767693466371866
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00534759	0.11767693466371866
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00534759	0.11767693466371866
CITRULLINE TRANSPORT DEFECT	0.00534759	0.11767693466371866
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00534759	0.11767693466371866
T-SUBSTANCE ANOMALY	0.00534759	0.11767693466371866
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00534759	0.11767693466371866
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00534759	0.11767693466371866
TYROSINE TRANSAMINASE DEFICIENCY	0.00534759	0.11767693466371866
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.00534759	0.11767693466371866
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00534759	0.11767693466371866
DIARRHEA 2, WITH MICROVILLOUS ATROPHY	0.00534759	0.11767693466371866
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00534759	0.11767693466371866
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.00534759	0.11767693466371866
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00534759	0.11767693466371866
#266600 INFLAMMATORY BOWEL DISEASE 1; IBD1REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED	0.00534759	0.11767693466371866
GLYCOGEN STORAGE DISEASE IXA	0.00534759	0.11767693466371866
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00534759	0.11767693466371866
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.00534759	0.11767693466371866
LYSINE MALABSORPTION SYNDROME	0.00534759	0.11767693466371866
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00534759	0.11767693466371866
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.00534759	0.11767693466371866
#613291 BILE ACID MALABSORPTION, PRIMARY; PBAM	0.00534759	0.11767693466371866
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00534759	0.11767693466371866
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00503038	0.11069653780369794
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00503038	0.11069653780369794
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00503038	0.11069653780369794
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00503038	0.11069653780369794
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00503038	0.11069653780369794
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00503038	0.11069653780369794
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00503038	0.11069653780369794
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00503038	0.11069653780369794
RETINITIS PIGMENTOSA 59; RP59	0.004732541	0.1041424114508348
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.004732541	0.1041424114508348
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.004732541	0.1041424114508348
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004732541	0.1041424114508348
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004732541	0.1041424114508348
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.004732541	0.1041424114508348
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004732541	0.1041424114508348
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004732541	0.1041424114508348
#615665 JOUBERT SYNDROME 22; JBTS22	0.004660672	0.10256089087477217
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.004660672	0.10256089087477217
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.004660672	0.10256089087477217
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.004660672	0.10256089087477217
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004660672	0.10256089087477217
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.004660672	0.10256089087477217
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.004660672	0.10256089087477217
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.004660672	0.10256089087477217
LOWRY-MACLEAN SYNDROME	0.004660672	0.10256089087477217
WARSAW BREAKAGE SYNDROME; WABS	0.004660672	0.10256089087477217
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.004660672	0.10256089087477217
GABRIELE-DE VRIES SYNDROME; GADEVS	0.004660672	0.10256089087477217
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00381679	0.08399075984791929
TRICHOHEPATOENTERIC SYNDROME 2	0.00381679	0.08399075984791929
NEU-LAXOVA SYNDROME 2; NLS2	0.00381679	0.08399075984791929
#260370 PANCREATIC AGENESIS, CONGENITAL; PAGEN;;PANCREATIC HYPOPLASIA, CONGENITAL	0.00381679	0.08399075984791929
BARTSOCAS-PAPAS SYNDROME; BPS	0.00381679	0.08399075984791929
MECKEL SYNDROME 12; MKS12	0.00381679	0.08399075984791929
VERVERI-BRADY SYNDROME; VERBRAS	0.00381679	0.08399075984791929
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.00381679	0.08399075984791929
MECKEL SYNDROME, TYPE 4; MKS4	0.00381679	0.08399075984791929
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00381679	0.08399075984791929
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00381679	0.08399075984791929
RESTRICTIVE DERMOPATHY, LETHAL	0.00381679	0.08399075984791929
HEMOCHROMATOSIS, NEONATAL	0.00381679	0.08399075984791929
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00381679	0.08399075984791929
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00381679	0.08399075984791929
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00381679	0.08399075984791929
MARTINEZ-FRIAS SYNDROME	0.00381679	0.08399075984791929
MITCHELL-RILEY SYNDROME; MTCHRS	0.00381679	0.08399075984791929
#613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10	0.00381679	0.08399075984791929
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00381679	0.08399075984791929
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00381679	0.08399075984791929
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00381679	0.08399075984791929
LAMBOTTE SYNDROME	0.00381679	0.08399075984791929
MEIER-GORLIN SYNDROME 8; MGORS8	0.00381679	0.08399075984791929
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00381679	0.08399075984791929
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00381679	0.08399075984791929
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00381679	0.08399075984791929
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00381679	0.08399075984791929
DIABETES MELLITUS, TRANSIENT NEONATAL, 1; TNDM1	0.00381679	0.08399075984791929
#256520 NEU-LAXOVA SYNDROME; NLS	0.00381679	0.08399075984791929
HYDROLETHALUS SYNDROME 1	0.00381679	0.08399075984791929
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00381679	0.08399075984791929
RUSSELL-SILVER SYNDROME, X-LINKED	0.00381679	0.08399075984791929
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00381679	0.08399075984791929
#614815 JOUBERT SYNDROME 18; JBTS18	0.00381679	0.08399075984791929
XQ25 DUPLICATION SYNDROME	0.0029732230000000005	0.06542756058554706
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.002973223	0.06542756058554705
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.002973223	0.06542756058554705
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.002973223	0.06542756058554705
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.002973223	0.06542756058554705
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.002973223	0.06542756058554705
LISSENCEPHALY 4	0.002973223	0.06542756058554705
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.002973223	0.06542756058554705
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.002973223	0.06542756058554705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.002973223	0.06542756058554705
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.002973223	0.06542756058554705
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.002973223	0.06542756058554705
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.002973223	0.06542756058554705
N-ACETYLASPARTATE DEFICIENCY; NACED	0.002973223	0.06542756058554705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.002973223	0.06542756058554705
HOLOPROSENCEPHALY 1; HPE1	0.002973223	0.06542756058554705
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.002973223	0.06542756058554705
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.002973223	0.06542756058554705
C SYNDROME	0.002973223	0.06542756058554705
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.002973223	0.06542756058554705
KBG SYNDROME	0.002973223	0.06542756058554705
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002973223	0.06542756058554705
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002973223	0.06542756058554705
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.002973223	0.06542756058554705
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.002973223	0.06542756058554705
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.002973223	0.06542756058554705
Pierpont syndrome	0.002973223	0.06542756058554705
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.002973223	0.06542756058554705
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002973223	0.06542756058554705
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.002973223	0.06542756058554705
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002973223	0.06542756058554705
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.002973223	0.06542756058554705
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002973223	0.06542756058554705
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.002973223	0.06542756058554705
CODAS SYNDROME	0.002973223	0.06542756058554705
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.002973223	0.06542756058554705
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.002973223	0.06542756058554705
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002973223	0.06542756058554705
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.002973223	0.06542756058554705
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.002973223	0.06542756058554705
WIEDEMANN-STEINER SYNDROME; WDSTS	0.002973223	0.06542756058554705
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002973223	0.06542756058554705
GLASS SYNDROME	0.002973223	0.06542756058554705
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002973223	0.06542756058554705
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.002973223	0.06542756058554705
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.002973223	0.06542756058554705
WIEACKER-WOLFF SYNDROME	0.002973223	0.06542756058554705
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002973223	0.06542756058554705
SCHAAF-YANG SYNDROME; SHFYNG	0.002973223	0.06542756058554705
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.002973223	0.06542756058554705
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.002973223	0.06542756058554705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002973223	0.06542756058554705
HARTNUP DISORDER	0.002973223	0.06542756058554705
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.002973223	0.06542756058554705
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.002973223	0.06542756058554705
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002973223	0.06542756058554705
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002973223	0.06542756058554705
CHROMOSOME 2q37 DELETION SYNDROME	0.002973223	0.06542756058554705
ATKIN-FLAITZ SYNDROME	0.002129341	0.04685742955869416
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.002129341	0.04685742955869416
GURRIERI SYNDROME	0.002129341	0.04685742955869416
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.002129341	0.04685742955869416
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.002129341	0.04685742955869416
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.002129341	0.04685742955869416
LOWE OCULOCEREBRORENAL SYNDROME	0.002129341	0.04685742955869416
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002129341	0.04685742955869416
COFFIN-LOWRY SYNDROME; CLS	0.002129341	0.04685742955869416
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.002129341	0.04685742955869416
SJOGREN-LARSSON SYNDROME; SLS	0.002129341	0.04685742955869416
2q33.1 deletion syndrome	0.002129341	0.04685742955869416
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.002129341	0.04685742955869416
AYME-GRIPP SYNDROME; AYGRP	0.002129341	0.04685742955869416
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002129341	0.04685742955869416
PERRAULT SYNDROME 3	0.002129341	0.04685742955869416
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.002129341	0.04685742955869416
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.002129341	0.04685742955869416
FOUNTAIN SYNDROME	0.002129341	0.04685742955869416
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.002129341	0.04685742955869416
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002129341	0.04685742955869416
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002129341	0.04685742955869416
CROME SYNDROME	0.002129341	0.04685742955869416
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.002129341	0.04685742955869416
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.002129341	0.04685742955869416
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002129341	0.04685742955869416
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.002129341	0.04685742955869416
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002129341	0.04685742955869416
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.002129341	0.04685742955869416
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.002129341	0.04685742955869416
HYPOPHOSPHATASIA, CHILDHOOD	0.002129341	0.04685742955869416
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.002129341	0.04685742955869416
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.002129341	0.04685742955869416
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.002129341	0.04685742955869416
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002129341	0.04685742955869416
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.0020574720000000003	0.04527590898263154
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0020574720000000003	0.04527590898263154
CEREBELLOFACIODENTAL SYNDROME	0.0020574720000000003	0.04527590898263154
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0020574720000000003	0.04527590898263154
COSTELLO SYNDROME; CSTLO	0.0020574720000000003	0.04527590898263154
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.0020574720000000003	0.04527590898263154
FRIAS SYNDROME	0.0020574720000000003	0.04527590898263154
NOONAN SYNDROME 6; NS6	0.0020574720000000003	0.04527590898263154
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0020574720000000003	0.04527590898263154
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0020574720000000003	0.04527590898263154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.0020574720000000003	0.04527590898263154
MENTAL RETARDATION, X-LINKED 99	0.0020574720000000003	0.04527590898263154
Retinitis pigmentosa with or without skeletal anomalies	0.0020574720000000003	0.04527590898263154
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0020574720000000003	0.04527590898263154
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.0020574720000000003	0.04527590898263154
ALAZAMI-YUAN SYNDROME	0.0020574720000000003	0.04527590898263154
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0020574720000000003	0.04527590898263154
#614728 SECKEL SYNDROME 6; SCKL6	0.0020574720000000003	0.04527590898263154
CHROMOSOME 18P DELETION SYNDROME	0.0020574720000000003	0.04527590898263154
STEEL SYNDROME; STLS	0.0020574720000000003	0.04527590898263154
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.0020574720000000003	0.04527590898263154
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.0020574720000000003	0.04527590898263154
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0020574720000000003	0.04527590898263154
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0020574720000000003	0.04527590898263154
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0020574720000000003	0.04527590898263154
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0020574720000000003	0.04527590898263154
NOONAN SYNDROME 3; NS3	0.0020574720000000003	0.04527590898263154
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0020574720000000003	0.04527590898263154
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.0020574720000000003	0.04527590898263154
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.0020574720000000003	0.04527590898263154
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.0020574720000000003	0.04527590898263154
NOONAN SYNDROME 5; NS5	0.0020574720000000003	0.04527590898263154
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0020574720000000003	0.04527590898263154
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.0020574720000000003	0.04527590898263154
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.0020574720000000003	0.04527590898263154
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0020574720000000003	0.04527590898263154
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0020574720000000003	0.04527590898263154
NOONAN SYNDROME 11; NS11	0.0020574720000000003	0.04527590898263154
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.0020574720000000003	0.04527590898263154
OROFACIODIGITAL SYNDROME VI	0.0020574720000000003	0.04527590898263154
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0020574720000000003	0.04527590898263154
COFFIN-SIRIS SYNDROME 6; CSS6	0.0020574720000000003	0.04527590898263154
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.0020574720000000003	0.04527590898263154
MEIER-GORLIN SYNDROME 7	0.0020574720000000003	0.04527590898263154
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0020574720000000003	0.04527590898263154
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.0020574720000000003	0.04527590898263154
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020574720000000003	0.04527590898263154
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.0020574720000000003	0.04527590898263154
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.0020574720000000003	0.04527590898263154
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0020574720000000003	0.04527590898263154
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.0020574720000000003	0.04527590898263154
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0020574720000000003	0.04527590898263154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0020574720000000003	0.04527590898263154
RAINE SYNDROME	0.0020574720000000003	0.04527590898263154
SECKEL SYNDROME 8; SCKL8	0.0020574720000000003	0.04527590898263154
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020574720000000003	0.04527590898263154
MARINESCO-SJOGREN SYNDROME; MSS	0.0020574720000000003	0.04527590898263154
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0020574720000000003	0.04527590898263154
OPTIC ATROPHY 11; OPA11	0.0020574720000000003	0.04527590898263154
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.0020574720000000003	0.04527590898263154
CRANIOFRONTONASAL SYNDROME; CFNS	0.0020574720000000003	0.04527590898263154
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.0020574720000000003	0.04527590898263154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.0020574720000000003	0.04527590898263154
HADZISELIMOVIC SYNDROME	0.0020574720000000003	0.04527590898263154
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0020574720000000003	0.04527590898263154
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0020574720000000003	0.04527590898263154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001759633	0.038721782629768414
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.038721782629768414
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.038721782629768414
ADAMS-OLIVER SYNDROME 2; AOS2	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.038721782629768414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.038721782629768414
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.038721782629768414
JABERI-ELAHI SYNDROME; JABELS	0.001759633	0.038721782629768414
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.001759633	0.038721782629768414
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001759633	0.038721782629768414
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.038721782629768414
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001759633	0.038721782629768414
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.038721782629768414
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001759633	0.038721782629768414
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.038721782629768414
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.038721782629768414
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001759633	0.038721782629768414
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.038721782629768414
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001759633	0.038721782629768414
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.038721782629768414
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001759633	0.038721782629768414
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.038721782629768414
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.038721782629768414
PHELAN-MCDERMID SYNDROME; PHMDS	0.001759633	0.038721782629768414
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.038721782629768414
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001759633	0.038721782629768414
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.038721782629768414
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.038721782629768414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001759633	0.038721782629768414
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001759633	0.038721782629768414
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.038721782629768414
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.001759633	0.038721782629768414
LISSENCEPHALY 8; LIS8	0.001759633	0.038721782629768414
Pontine tegmental cap dysplasia	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001759633	0.038721782629768414
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001759633	0.038721782629768414
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.038721782629768414
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.038721782629768414
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001759633	0.038721782629768414
HOLOPROSENCEPHALY 7	0.001759633	0.038721782629768414
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.038721782629768414
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.038721782629768414
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.038721782629768414
PEHO SYNDROME; PEHO	0.001759633	0.038721782629768414
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001759633	0.038721782629768414
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.038721782629768414
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.038721782629768414
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.038721782629768414
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001759633	0.038721782629768414
LEIGH SYNDROME; LS	0.001759633	0.038721782629768414
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.038721782629768414
PETTIGREW SYNDROME	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001759633	0.038721782629768414
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001759633	0.038721782629768414
ARGININOSUCCINIC ACIDURIA	0.001759633	0.038721782629768414
Cerebral creatine deficiency syndrome 2	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.038721782629768414
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.038721782629768414
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.038721782629768414
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.038721782629768414
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.038721782629768414
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.038721782629768414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001759633	0.038721782629768414
SCHINDLER DISEASE, TYPE I	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001759633	0.038721782629768414
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.038721782629768414
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.038721782629768414
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001759633	0.038721782629768414
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001759633	0.038721782629768414
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001759633	0.038721782629768414
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.038721782629768414
WEAVER SYNDROME	0.001759633	0.038721782629768414
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.038721782629768414
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001759633	0.038721782629768414
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.038721782629768414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.038721782629768414
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.038721782629768414
LANDAU-KLEFFNER SYNDROME	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.001759633	0.038721782629768414
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001759633	0.038721782629768414
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001759633	0.038721782629768414
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.038721782629768414
LISSENCEPHALY 1; LIS1	0.001759633	0.038721782629768414
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001759633	0.038721782629768414
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.038721782629768414
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.038721782629768414
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.038721782629768414
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.038721782629768414
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.038721782629768414
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.038721782629768414
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001759633	0.038721782629768414
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001759633	0.038721782629768414
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.038721782629768414
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.038721782629768414
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.038721782629768414
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.038721782629768414
Glycosylphosphatidylinositol biosynthesis defect 18	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.038721782629768414
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001759633	0.038721782629768414
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001759633	0.038721782629768414
SULFOCYSTEINURIA	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.038721782629768414
DESANTO-SHINAWI SYNDROME	0.001759633	0.038721782629768414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001759633	0.038721782629768414
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001759633	0.038721782629768414
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001759633	0.038721782629768414
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.038721782629768414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001759633	0.038721782629768414
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.038721782629768414
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.038721782629768414
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.038721782629768414
HYPEREKPLEXIA 4; HKPX4	0.001759633	0.038721782629768414
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.038721782629768414
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.038721782629768414
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.038721782629768414
KETOADIPICACIDURIA	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001759633	0.038721782629768414
ELEJALDE DISEASE	0.001759633	0.038721782629768414
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.038721782629768414
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.038721782629768414
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001759633	0.038721782629768414
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.038721782629768414
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001759633	0.038721782629768414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.038721782629768414
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.038721782629768414
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.038721782629768414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.038721782629768414
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.038721782629768414
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.038721782629768414
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.038721782629768414
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.038721782629768414
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001759633	0.038721782629768414
ANGELMAN SYNDROME	0.001759633	0.038721782629768414
SHASHI-PENA SYNDROME; SHAPNS	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.038721782629768414
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.038721782629768414
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001759633	0.038721782629768414
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001759633	0.038721782629768414
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.038721782629768414
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.038721782629768414
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.038721782629768414
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001759633	0.038721782629768414
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001759633	0.038721782629768414
HOLOPROSENCEPHALY 2; HPE2	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.038721782629768414
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001759633	0.038721782629768414
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001759633	0.038721782629768414
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.038721782629768414
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.001759633	0.038721782629768414
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.038721782629768414
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001759633	0.038721782629768414
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.038721782629768414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.038721782629768414
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.038721782629768414
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.038721782629768414
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.001759633	0.038721782629768414
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.038721782629768414
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.038721782629768414
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 90	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001759633	0.038721782629768414
CHROMOSOME 19p13.13 DELETION SYNDROME	0.001759633	0.038721782629768414
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.001759633	0.038721782629768414
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.038721782629768414
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.038721782629768414
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001759633	0.038721782629768414
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001759633	0.038721782629768414
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.038721782629768414
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001759633	0.038721782629768414
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.038721782629768414
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001759633	0.038721782629768414
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.038721782629768414
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001759633	0.038721782629768414
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001759633	0.038721782629768414
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.038721782629768414
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001759633	0.038721782629768414
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001759633	0.038721782629768414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.038721782629768414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.038721782629768414
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.038721782629768414
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.038721782629768414
MENTAL RETARDATION, X-LINKED 2	0.00121359	0.026705777955778644
FOCAL DERMAL HYPOPLASIA; FDH	0.00121359	0.026705777955778644
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00121359	0.026705777955778644
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00121359	0.026705777955778644
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00121359	0.026705777955778644
BRACHYDACTYLY, TYPE A6	0.00121359	0.026705777955778644
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00121359	0.026705777955778644
WERNER SYNDROME; WRN	0.00121359	0.026705777955778644
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00121359	0.026705777955778644
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00121359	0.026705777955778644
NOONAN SYNDROME 4; NS4	0.00121359	0.026705777955778644
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00121359	0.026705777955778644
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00121359	0.026705777955778644
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00121359	0.026705777955778644
#615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3	0.00121359	0.026705777955778644
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00121359	0.026705777955778644
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00121359	0.026705777955778644
SACCHAROPINURIA	0.00121359	0.026705777955778644
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00121359	0.026705777955778644
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00121359	0.026705777955778644
600736 VELOFACIOSKELETAL SYNDROME	0.00121359	0.026705777955778644
SPONDYLOOCULAR SYNDROME; SOS	0.00121359	0.026705777955778644
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00121359	0.026705777955778644
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00121359	0.026705777955778644
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00121359	0.026705777955778644
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00121359	0.026705777955778644
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00121359	0.026705777955778644
LATERAL MENINGOCELE SYNDROME	0.00121359	0.026705777955778644
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00121359	0.026705777955778644
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00121359	0.026705777955778644
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00121359	0.026705777955778644
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00121359	0.026705777955778644
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00121359	0.026705777955778644
260150 PALANT CLEFT PALATE SYNDROME	0.00121359	0.026705777955778644
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00121359	0.026705777955778644
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00121359	0.026705777955778644
OVARIAN DYSGENESIS 4; ODG4	0.00121359	0.026705777955778644
KENNERKNECHT SYNDROME	0.00121359	0.026705777955778644
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00121359	0.026705777955778644
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00121359	0.026705777955778644
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00121359	0.026705777955778644
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00121359	0.026705777955778644
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00121359	0.026705777955778644
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00121359	0.026705777955778644
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00121359	0.026705777955778644
GLYCOGEN STORAGE DISEASE IXB	0.00121359	0.026705777955778644
608028 THAI SYMPHALANGISM SYNDROME	0.00121359	0.026705777955778644
OCULOPALATOCEREBRAL SYNDROME	0.00121359	0.026705777955778644
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00121359	0.026705777955778644
SPINAL DYSPLASIA, ANHALT TYPE	0.00121359	0.026705777955778644
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00121359	0.026705777955778644
HAIRY ELBOWS	0.00121359	0.026705777955778644
HYPERTELORISM, TEEBI TYPE; TBHS	0.00121359	0.026705777955778644
EIKEN SYNDROME	0.00121359	0.026705777955778644
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00121359	0.026705777955778644
MENTAL RETARDATION, X-LINKED 84	0.00121359	0.026705777955778644
Orofaciodigital syndrome XVII	0.00121359	0.026705777955778644
FEINGOLD SYNDROME 2; FGLDS2	0.00121359	0.026705777955778644
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00121359	0.026705777955778644
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00121359	0.026705777955778644
DENT DISEASE 1	0.00121359	0.026705777955778644
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00121359	0.026705777955778644
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00121359	0.026705777955778644
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00121359	0.026705777955778644
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	0.00121359	0.026705777955778644
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00121359	0.026705777955778644
#615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11	0.00121359	0.026705777955778644
RAPADILINO SYNDROME	0.00121359	0.026705777955778644
EXOSTOSES, MULTIPLE, TYPE II	0.00121359	0.026705777955778644
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00121359	0.026705777955778644
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00121359	0.026705777955778644
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00121359	0.026705777955778644
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00121359	0.026705777955778644
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00121359	0.026705777955778644
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00121359	0.026705777955778644
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00121359	0.026705777955778644
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00121359	0.026705777955778644
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00121359	0.026705777955778644
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.00121359	0.026705777955778644
#300582 SHORT STATURE, IDIOPATHIC, X-LINKED; ISS	0.00121359	0.026705777955778644
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00121359	0.026705777955778644
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00121359	0.026705777955778644
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00121359	0.026705777955778644
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00121359	0.026705777955778644
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00121359	0.026705777955778644
HYPOPHOSPHATEMIC BONE DISEASE	0.00121359	0.026705777955778644
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	0.00121359	0.026705777955778644
CORNEODERMATOOSSEOUS SYNDROME	0.00121359	0.026705777955778644
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00121359	0.026705777955778644
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00121359	0.026705777955778644
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00121359	0.026705777955778644
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00121359	0.026705777955778644
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00121359	0.026705777955778644
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00121359	0.026705777955778644
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00121359	0.026705777955778644
SPASTIC PARAPARESIS AND DEAFNESS	0.00121359	0.026705777955778644
PELVIS-SHOULDER DYSPLASIA	0.00121359	0.026705777955778644
MENTAL RETARDATION, X-LINKED 92	0.00121359	0.026705777955778644
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00121359	0.026705777955778644
MASA SYNDROME	0.00121359	0.026705777955778644
245800 LAURENCE-MOON SYNDROME	0.00121359	0.026705777955778644
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00121359	0.026705777955778644
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00121359	0.026705777955778644
AROMATASE EXCESS SYNDROME	0.00121359	0.026705777955778644
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00121359	0.026705777955778644
LOEYS-DIETZ SYNDROME 5	0.00121359	0.026705777955778644
NASODIGITOACOUSTIC SYNDROME	0.00121359	0.026705777955778644
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.00121359	0.026705777955778644
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00121359	0.026705777955778644
22q11.2 distal deletion syndrome	0.00121359	0.026705777955778644
Rothmund-Thomson syndrome	0.00121359	0.026705777955778644
BRUCK SYNDROME 2	0.00121359	0.026705777955778644
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00121359	0.026705777955778644
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00121359	0.026705777955778644
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00121359	0.026705777955778644
Smith-Magenis Syndrome	0.00121359	0.026705777955778644
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00121359	0.026705777955778644
THREE M SYNDROME 2; 3M2	0.00121359	0.026705777955778644
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00121359	0.026705777955778644
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00121359	0.026705777955778644
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00121359	0.026705777955778644
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00121359	0.026705777955778644
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00121359	0.026705777955778644
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00121359	0.026705777955778644
OROFACIODIGITAL SYNDROME IV; OFD4	0.00121359	0.026705777955778644
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00121359	0.026705777955778644
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00121359	0.026705777955778644
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00121359	0.026705777955778644
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00121359	0.026705777955778644
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00121359	0.026705777955778644
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00121359	0.026705777955778644
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00121359	0.026705777955778644
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00121359	0.026705777955778644
LEGG-CALVE-PERTHES DISEASE	0.00121359	0.026705777955778644
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00121359	0.026705777955778644
THORACOPELVIC DYSOSTOSIS	0.00121359	0.026705777955778644
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00121359	0.026705777955778644
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00121359	0.026705777955778644
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00121359	0.026705777955778644
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00121359	0.026705777955778644
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00121359	0.026705777955778644
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00121359	0.026705777955778644
15q24 recurrent microdeletion syndrome	0.00121359	0.026705777955778644
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00121359	0.026705777955778644
RUIJS-AALFS SYNDROME; RJALS	0.00121359	0.026705777955778644
#613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2	0.00121359	0.026705777955778644
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00121359	0.026705777955778644
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	0.00121359	0.026705777955778644
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00121359	0.026705777955778644
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00121359	0.026705777955778644
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00121359	0.026705777955778644
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00121359	0.026705777955778644
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00121359	0.026705777955778644
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00121359	0.026705777955778644
ACROCRANIOFACIAL DYSOSTOSIS	0.00121359	0.026705777955778644
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00121359	0.026705777955778644
#611554 LEOPARD SYNDROME 2	0.00121359	0.026705777955778644
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00121359	0.026705777955778644
STIFF SKIN SYNDROME	0.00121359	0.026705777955778644
#614205 THREE M SYNDROME 3; 3M3;;3@M SYNDROME 3	0.00121359	0.026705777955778644
MUCOLIPIDOSIS III ALPHA/BETA	0.00121359	0.026705777955778644
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00121359	0.026705777955778644
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00121359	0.026705777955778644
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00121359	0.026705777955778644
WARBURG MICRO SYNDROME 1	0.00121359	0.026705777955778644
SECKEL SYNDROME 5; SCKL5	0.00121359	0.026705777955778644
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00121359	0.026705777955778644
SHPRINTZEN OMPHALOCELE SYNDROME	0.00121359	0.026705777955778644
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00121359	0.026705777955778644
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.00121359	0.026705777955778644
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00121359	0.026705777955778644
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00121359	0.026705777955778644
SPONDYLOPERIPHERAL DYSPLASIA	0.00121359	0.026705777955778644
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00121359	0.026705777955778644
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00121359	0.026705777955778644
OVARIAN DYSGENESIS 5; ODG5	0.00121359	0.026705777955778644
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00121359	0.026705777955778644
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00121359	0.026705777955778644
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00121359	0.026705777955778644
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00121359	0.026705777955778644
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00121359	0.026705777955778644
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00121359	0.026705777955778644
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00121359	0.026705777955778644
AURICULOOSTEODYSPLASIA	0.00121359	0.026705777955778644
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00121359	0.026705777955778644
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00121359	0.026705777955778644
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00121359	0.026705777955778644
SATOYOSHI SYNDROME	0.00121359	0.026705777955778644
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00121359	0.026705777955778644
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00121359	0.026705777955778644
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00121359	0.026705777955778644
STICKLER SYNDROME, TYPE V; STL5	0.00121359	0.026705777955778644
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00121359	0.026705777955778644
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00121359	0.026705777955778644
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00121359	0.026705777955778644
#259450 BRUCK SYNDROME 1; BRKS1	0.00121359	0.026705777955778644
MACS SYNDROME	0.00121359	0.026705777955778644
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00121359	0.026705777955778644
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00121359	0.026705777955778644
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00121359	0.026705777955778644
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00121359	0.026705777955778644
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00121359	0.026705777955778644
THUMB DEFORMITY AND ALOPECIA	0.00121359	0.026705777955778644
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00121359	0.026705777955778644
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00121359	0.026705777955778644
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.00121359	0.026705777955778644
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00121359	0.026705777955778644
SAY SYNDROME	0.00121359	0.026705777955778644
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00121359	0.026705777955778644
BRACHYDACTYLY, TYPE E2; BDE2	0.00121359	0.026705777955778644
#276880 UROCANASE DEFICIENCY	0.00121359	0.026705777955778644
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00121359	0.026705777955778644
SONODA SYNDROME	0.00121359	0.026705777955778644
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00121359	0.026705777955778644
RODRIGUES BLINDNESS	0.00121359	0.026705777955778644
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00121359	0.026705777955778644
EXOSTOSES, MULTIPLE, TYPE I	0.00121359	0.026705777955778644
ANAUXETIC DYSPLASIA 2; ANXD2	0.00121359	0.026705777955778644
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00121359	0.026705777955778644
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00121359	0.026705777955778644
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00121359	0.026705777955778644
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00121359	0.026705777955778644
Cat-Eye Syndrome (Type I)	0.00121359	0.026705777955778644
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00121359	0.026705777955778644
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00121359	0.026705777955778644
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00121359	0.026705777955778644
#154780 MARSHALL SYNDROME; MRSHS	0.00121359	0.026705777955778644
MENTAL RETARDATION, X-LINKED 45	0.00121359	0.026705777955778644
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00121359	0.026705777955778644
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00121359	0.026705777955778644
COXOAURICULAR SYNDROME	0.00121359	0.026705777955778644
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00121359	0.026705777955778644
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00121359	0.026705777955778644
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00121359	0.026705777955778644
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00121359	0.026705777955778644
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00121359	0.026705777955778644
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.00121359	0.026705777955778644
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00121359	0.026705777955778644
CHARGE-LIKE SYNDROME, X-LINKED	0.00121359	0.026705777955778644
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00121359	0.026705777955778644
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00121359	0.026705777955778644
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00121359	0.026705777955778644
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.00121359	0.026705777955778644
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00121359	0.026705777955778644
NOONAN SYNDROME 8; NS8	0.00121359	0.026705777955778644
#278250 WRINKLY SKIN SYNDROME; WSS	0.00121359	0.026705777955778644
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00121359	0.026705777955778644
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00121359	0.026705777955778644
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00121359	0.026705777955778644
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00121359	0.026705777955778644
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00121359	0.026705777955778644
#613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6	0.00121359	0.026705777955778644
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	0.00121359	0.026705777955778644
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.00121359	0.026705777955778644
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00121359	0.026705777955778644
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00121359	0.026705777955778644
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00121359	0.026705777955778644
RADIAL-RENAL SYNDROME	0.00121359	0.026705777955778644
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.020151651602915523
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.020151651602915523
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.020151651602915523
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.020151651602915523
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.020151651602915523
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.020151651602915523
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000915751	0.020151651602915523
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.020151651602915523
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.020151651602915523
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.020151651602915523
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.020151651602915523
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.020151651602915523
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.020151651602915523
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.020151651602915523
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.020151651602915523
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.020151651602915523
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.020151651602915523
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.020151651602915523
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.020151651602915523
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.020151651602915523
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.020151651602915523
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.020151651602915523
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.020151651602915523
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.020151651602915523
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.020151651602915523
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.020151651602915523
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.020151651602915523
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.020151651602915523
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000915751	0.020151651602915523
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.020151651602915523
HYPERPROLINEMIA, TYPE II	0.000915751	0.020151651602915523
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000915751	0.020151651602915523
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.020151651602915523
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.020151651602915523
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.020151651602915523
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.020151651602915523
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.020151651602915523
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.020151651602915523
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.020151651602915523
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.020151651602915523
COFFIN-SIRIS SYNDROME 8; CSS8	0.000915751	0.020151651602915523
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.020151651602915523
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.020151651602915523
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.020151651602915523
AUTISM	0.000915751	0.020151651602915523
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.020151651602915523
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.020151651602915523
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000915751	0.020151651602915523
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.020151651602915523
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.020151651602915523
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.020151651602915523
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.020151651602915523
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.020151651602915523
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.020151651602915523
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.020151651602915523
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.020151651602915523
CLARK-BARAITSER SYNDROME	0.000915751	0.020151651602915523
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.020151651602915523
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.020151651602915523
POTOCKI-SHAFFER SYNDROME	0.000915751	0.020151651602915523
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.020151651602915523
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.020151651602915523
EPILEPSY-TELANGIECTASIA	0.000915751	0.020151651602915523
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.020151651602915523
Wolf-Hirschhorn Syndrome	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.020151651602915523
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.020151651602915523
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.020151651602915523
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.020151651602915523
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.020151651602915523
1p36 microdeletion syndrome	0.000915751	0.020151651602915523
XYLOSIDASE DEFICIENCY	0.000915751	0.020151651602915523
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000915751	0.020151651602915523
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.020151651602915523
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.020151651602915523
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.020151651602915523
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.020151651602915523
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.020151651602915523
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.020151651602915523
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.020151651602915523
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.020151651602915523
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.020151651602915523
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.020151651602915523
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.020151651602915523
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.020151651602915523
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.020151651602915523
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.020151651602915523
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.020151651602915523
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.020151651602915523
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.020151651602915523
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.020151651602915523
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.020151651602915523
LISSENCEPHALY 3; LIS3	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.020151651602915523
DARIER-WHITE DISEASE; DAR	0.000915751	0.020151651602915523
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.000915751	0.020151651602915523
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.020151651602915523
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.020151651602915523
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000915751	0.020151651602915523
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.020151651602915523
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.020151651602915523
Angelman syndrome (Type 1)	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.020151651602915523
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000915751	0.020151651602915523
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.020151651602915523
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.020151651602915523
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.020151651602915523
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000915751	0.020151651602915523
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.020151651602915523
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.020151651602915523
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.020151651602915523
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.020151651602915523
DIAMINOPENTANURIA	0.000915751	0.020151651602915523
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.020151651602915523
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.020151651602915523
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.020151651602915523
LISSENCEPHALY 5; LIS5	0.000915751	0.020151651602915523
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.020151651602915523
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.020151651602915523
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.020151651602915523
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.020151651602915523
FRYNS SYNDROME; FRNS	0.000915751	0.020151651602915523
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.020151651602915523
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.020151651602915523
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.020151651602915523
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.000915751	0.020151651602915523
PHENYLKETONURIA	0.000915751	0.020151651602915523
15q13.3 microdeletion syndrome	0.000915751	0.020151651602915523
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.020151651602915523
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.020151651602915523
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.020151651602915523
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.020151651602915523
KIFAFA SEIZURE DISORDER	0.000915751	0.020151651602915523
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.020151651602915523
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.020151651602915523
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.020151651602915523
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000915751	0.020151651602915523
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.020151651602915523
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.020151651602915523
STURGE-WEBER SYNDROME	0.000915751	0.020151651602915523
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.020151651602915523
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.020151651602915523
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.020151651602915523
HYPER-BETA-ALANINEMIA	0.000915751	0.020151651602915523
PITT-HOPKINS SYNDROME	0.000915751	0.020151651602915523
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.020151651602915523
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.020151651602915523
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.020151651602915523
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.020151651602915523
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.020151651602915523
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.020151651602915523
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.020151651602915523
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.020151651602915523
CROUZON SYNDROME	0.000915751	0.020151651602915523
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.020151651602915523
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.020151651602915523
PAPILLORENAL SYNDROME	0.000915751	0.020151651602915523
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.000915751	0.020151651602915523
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.020151651602915523
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.020151651602915523
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.020151651602915523
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.000915751	0.020151651602915523
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.020151651602915523
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.020151651602915523
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.020151651602915523
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.020151651602915523
ALEXANDER DISEASE	0.000915751	0.020151651602915523
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.020151651602915523
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.020151651602915523
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.020151651602915523
Angelman syndrome (Type 2)	0.000915751	0.020151651602915523
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.020151651602915523
EPILEPSY, READING	0.000915751	0.020151651602915523
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.020151651602915523
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.020151651602915523
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.020151651602915523
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.020151651602915523
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.020151651602915523
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.020151651602915523
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.020151651602915523
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.020151651602915523
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.020151651602915523
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.020151651602915523
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.020151651602915523
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000915751	0.020151651602915523
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.020151651602915523
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.020151651602915523
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.020151651602915523
OCULODENTODIGITAL DYSPLASIA; ODDD	0.000915751	0.020151651602915523
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.020151651602915523
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.020151651602915523
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000915751	0.020151651602915523
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.018570131026852885
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.018570131026852885
JOUBERT SYNDROME 27	0.000843882	0.018570131026852885
CURRY-JONES SYNDROME	0.000843882	0.018570131026852885
JOUBERT SYNDROME 1	0.000843882	0.018570131026852885
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.018570131026852885
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.018570131026852885
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.018570131026852885
JOUBERT SYNDROME 21	0.000843882	0.018570131026852885
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.018570131026852885
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.018570131026852885
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.018570131026852885
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000843882	0.018570131026852885
Leukotriene C4 synthase deficiency	0.000843882	0.018570131026852885
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.018570131026852885
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.018570131026852885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.018570131026852885
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.018570131026852885
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.018570131026852885
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.018570131026852885
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.018570131026852885
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.018570131026852885
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.018570131026852885
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.018570131026852885
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000843882	0.018570131026852885
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.018570131026852885
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.018570131026852885
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.018570131026852885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.018570131026852885
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.018570131026852885
YOU-HOOVER-FONG SYNDROME; YHFS	0.000843882	0.018570131026852885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.018570131026852885
XIA-GIBBS SYNDROME	0.000843882	0.018570131026852885
Bardet-Biedl syndrome 2	0.000843882	0.018570131026852885
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.018570131026852885
AL-RAQAD SYNDROME; ARS	0.000843882	0.018570131026852885
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.018570131026852885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.018570131026852885
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.018570131026852885
JOUBERT SYNDROME 15	0.000843882	0.018570131026852885
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.018570131026852885
JOUBERT SYNDROME 7	0.000843882	0.018570131026852885
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000843882	0.018570131026852885
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000843882	0.018570131026852885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.018570131026852885
FRONTOOCULAR SYNDROME	0.000843882	0.018570131026852885
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.018570131026852885
HOLOPROSENCEPHALY 11	0.000843882	0.018570131026852885
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.018570131026852885
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.018570131026852885
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.018570131026852885
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.018570131026852885
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.018570131026852885
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.018570131026852885
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.018570131026852885
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.018570131026852885
GOLDBERG-SHPRINTZEN SYNDROME	0.000843882	0.018570131026852885
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.018570131026852885
Cerebral creatine deficiency syndrome 3	0.000843882	0.018570131026852885
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.018570131026852885
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.018570131026852885
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.018570131026852885
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.018570131026852885
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.018570131026852885
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.018570131026852885
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.018570131026852885
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.018570131026852885
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.018570131026852885
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000843882	0.018570131026852885
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.018570131026852885
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.018570131026852885
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.018570131026852885
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.018570131026852885
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.018570131026852885
JOUBERT SYNDROME 24	0.000843882	0.018570131026852885
AUSTRALIA ANTIGEN	0.000843882	0.018570131026852885
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.018570131026852885
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.018570131026852885
JOUBERT SYNDROME 6	0.000843882	0.018570131026852885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.018570131026852885
Jawad syndrome	0.000843882	0.018570131026852885
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.018570131026852885
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.018570131026852885
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.018570131026852885
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.018570131026852885
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.018570131026852885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.018570131026852885
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.018570131026852885
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.018570131026852885
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.018570131026852885
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.018570131026852885
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.018570131026852885
SENIOR-LOKEN SYNDROME 9	0.000843882	0.018570131026852885
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000843882	0.018570131026852885
CHAR SYNDROME	0.000843882	0.018570131026852885
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.018570131026852885
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.018570131026852885
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.018570131026852885
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.018570131026852885
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.018570131026852885
PELLAGRA-LIKE SYNDROME	0.000843882	0.018570131026852885
JOUBERT SYNDROME 28	0.000843882	0.018570131026852885
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.018570131026852885
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.018570131026852885
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.018570131026852885
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.018570131026852885
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.018570131026852885
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.018570131026852885
ARIMA SYNDROME	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000843882	0.018570131026852885
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.018570131026852885
JOUBERT SYNDROME 8	0.000843882	0.018570131026852885
WAARDENBURG-SHAH SYNDROME	0.000843882	0.018570131026852885
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.018570131026852885
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.018570131026852885
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.018570131026852885
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.018570131026852885
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.018570131026852885
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.018570131026852885
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.018570131026852885
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.018570131026852885
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.018570131026852885
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.018570131026852885
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.018570131026852885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.018570131026852885
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.018570131026852885
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.018570131026852885
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.018570131026852885
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.018570131026852885
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.018570131026852885
GENITOPATELLAR SYNDROME; GTPTS	0.000843882	0.018570131026852885
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.018570131026852885
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.018570131026852885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.018570131026852885
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.018570131026852885
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.018570131026852885
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.018570131026852885
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.018570131026852885
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.018570131026852885
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.018570131026852885
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.018570131026852885
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.018570131026852885
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.018570131026852885
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.018570131026852885
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.018570131026852885
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.018570131026852885
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.018570131026852885
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.018570131026852885
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.018570131026852885
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.018570131026852885
PEROXISOME BIOGENESIS DISORDER 6B	0.000843882	0.018570131026852885
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.018570131026852885
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.018570131026852885
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.018570131026852885
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.018570131026852885
CRANIOSYNOSTOSIS 6; CRS6	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.018570131026852885
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.018570131026852885
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.018570131026852885
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.018570131026852885
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.018570131026852885
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.018570131026852885
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.018570131026852885
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.018570131026852885
LAMB-SHAFFER SYNDROME	0.000843882	0.018570131026852885
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.018570131026852885
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.018570131026852885
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.018570131026852885
RAHMAN SYNDROME	0.000843882	0.018570131026852885
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000843882	0.018570131026852885
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.018570131026852885
JOUBERT SYNDROME 25	0.000843882	0.018570131026852885
ELSAHY-WATERS SYNDROME; ESWS	0.000843882	0.018570131026852885
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.018570131026852885
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.018570131026852885
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.018570131026852885
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.018570131026852885
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.018570131026852885
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.018570131026852885
AU-KLINE SYNDROME; AUKS	0.000843882	0.018570131026852885
COHEN-GIBSON SYNDROME; COGIS	0.000843882	0.018570131026852885
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.018570131026852885
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.018570131026852885
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.018570131026852885
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.018570131026852885
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.018570131026852885
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.018570131026852885
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.018570131026852885
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.018570131026852885
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.018570131026852885
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.018570131026852885
MECKEL SYNDROME 13; MKS13	0.000843882	0.018570131026852885
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.018570131026852885
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.018570131026852885
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.018570131026852885
Temtamy preaxial brachydactyly syndrome	0.000843882	0.018570131026852885
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.018570131026852885
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.018570131026852885
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.018570131026852885
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.018570131026852885
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000843882	0.018570131026852885
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.018570131026852885
CDAGS SYNDROME	0.000843882	0.018570131026852885
